HT - Height (24 months) Gene
Species: Bos taurus
Gene Type: unknown
Gene ID: 105753515
Related Agents
- Approval
- Clinical Phase
- Pre-clinical Phase
Approval
Bioactive Molecules
(228)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-12708 | Chlorpromazine | 99.75% | Unkown | |
| HY-B1473A | Serotonin | 99.86% | Unkown | |
| HY-B1473 | Serotonin hydrochloride | 99.97% | Unkown | |
| HY-N0145 | Puerarin | Antagonist | 99.06% | Yes |
| HY-B0407A | Chlorpromazine hydrochloride | 99.90% | Unkown | |
| HY-14539 | Clozapine | 99.84% | Yes | |
| HY-14541 | Olanzapine | 99.96% | Yes | |
| HY-N0122 | 5-Hydroxytryptophan | Agonist | 99.92% | Unkown |
| HY-11018 | Risperidone | 99.87% | Yes | |
| HY-15414 | Vortioxetine | Inhibitor | 98.61% | Yes |
| HY-122272 | Paroxetine | 99.66% | Yes | |
| HY-B0607 | Nitisinone | 99.93% | Yes | |
| HY-B0492 | Paroxetine hydrochloride | 99.98% | Unkown | |
| HY-14546 | Aripiprazole | Agonist | 99.95% | Yes |
| HY-10562 | Ketanserin | 99.89% | Unkown | |
| HY-15780 | Brexpiprazole | 99.80% | Unkown | |
| HY-14262 | Vilazodone | 99.73% | Unkown | |
| HY-14557 | Pimavanserin | Inhibitor | 99.86% | Yes |
| HY-B0002B | Ondansetron | Antagonist | 99.40% | Yes |
| HY-15414A | Vortioxetine hydrobromide | Inhibitor | 99.87% | Yes |
| HY-15296 | Cabergoline | 99.86% | Yes | |
| HY-B1115A | Buspirone | 99.86% | Yes | |
| HY-119209 | Nefazodone | Inhibitor | 98.01% | Unkown |
| HY-14149 | Cisapride | 99.87% | Yes | |
| HY-14151 | Prucalopride | 99.93% | Yes | |
| HY-B0527 | Amitriptyline | 99.94% | Yes | |
| HY-B0982 | Pindolol | Antagonist | 99.92% | Unkown |
| HY-14544 | Quetiapine | 99.93% | Yes | |
| HY-B0196 | Venlafaxine | Inhibitor | 99.71% | Yes |
| HY-B0527A | Amitriptyline hydrochloride | 99.94% | Yes | |
| HY-14261 | Vilazodone Hydrochloride | 99.94% | Unkown | |
| HY-B0352 | Mirtazapine | Antagonist | 99.94% | Unkown |
| HY-14763 | Cariprazine | Modulator | 99.67% | Yes |
| HY-17385 | Atomoxetine hydrochloride | Inhibitor | 99.91% | Yes |
| HY-14153A | Tegaserod maleate | 99.90% | Unkown | |
| HY-A0019 | Paliperidone | Antagonist | 99.43% | Unkown |
| HY-75502 | Rotigotine | 99.98% | Yes | |
| HY-14542 | Ziprasidone | Antagonist | 99.31% | Unkown |
| HY-14543 | Sertindole | 99.92% | Unkown | |
| HY-W010892 | Scopolamine hydrobromide trihydrate | Antagonist | 99.96% | Unkown |
| HY-B0457A | Clomipramine | Inhibitor | 99.64% | Unkown |
| HY-B0121B | Sumatriptan | Agonist | 99.96% | Unkown |
| HY-B1371 | Spiperone | 99.00% | Unkown | |
| HY-A0077 | Perphenazine | 99.81% | Unkown | |
| HY-A0007 | Rotigotine Hydrochloride | 99.45% | Yes | |
| HY-B0032A | Lurasidone | 99.92% | Unkown | |
| HY-B1517 | Alprenolol | Antagonist | 99.94% | Unkown |
| HY-14545 | Amisulpride | Antagonist | 99.77% | Unkown |
| HY-B1115 | Buspirone hydrochloride | 99.99% | Yes | |
| HY-70050C | Alosetron Hydrochloride | Antagonist | 99.63% | Unkown |
| HY-14763A | Cariprazine hydrochloride | Modulator | 99.88% | Yes |
| HY-10564 | Sarpogrelate hydrochloride | Antagonist | 99.09% | Unkown |
| HY-17038 | Agomelatine | 99.55% | Yes | |
| HY-17382 | Metoclopramide | Antagonist | 99.98% | Unkown |
| HY-17637 | Lumateperone | 99.83% | Unkown | |
| HY-B0002A | Ondansetron hydrochloride dihydrate | Antagonist | 99.93% | Unkown |
| HY-B0457 | Clomipramine hydrochloride | Inhibitor | 99.56% | Unkown |
| HY-14153 | Tegaserod | 99.71% | Unkown | |
| HY-122422 | Gepirone | 99.88% | Unkown | |
| HY-17390A | Loxapine succinate | 98.84% | Unkown | |
| HY-N0096 | Rotundine | Antagonist | 99.96% | Unkown |
| HY-13575 | Blonanserin | Antagonist | 99.91% | Unkown |
| HY-B1033 | Metergoline | 99.94% | Unkown | |
| HY-B0196A | Venlafaxine hydrochloride | Inhibitor | 99.58% | Yes |
| HY-B1287 | Citalopram hydrobromide | 99.87% | Yes | |
| HY-B0071 | Granisetron | Antagonist | 99.88% | Unkown |
| HY-10562A | Ketanserin tartrate | 99.93% | Unkown | |
| HY-B0991 | Amoxapine | 99.96% | Yes | |
| HY-B1517A | Alprenolol hydrochloride | Antagonist | 99.63% | Unkown |
| HY-12694 | Prucalopride succinate | 99.94% | Yes | |
| HY-A0021 | Palonosetron hydrochloride | Antagonist | 99.94% | Unkown |
| HY-B0031 | Quetiapine hemifumarate | 99.96% | Yes | |
| HY-B1622 | Cyproheptadine | 99.92% | Unkown | |
| HY-14557A | Pimavanserin hemitartrate | Inhibitor | 99.91% | Yes |
| HY-17390 | Loxapine | 99.93% | Unkown | |
| HY-B0002 | Ondansetron hydrochloride | Antagonist | 99.93% | Unkown |
| HY-B1213 | Trimipramine maleate | 99.88% | Unkown | |
| HY-B0781 | Promethazine hydrochloride | Antagonist | 99.85% | Unkown |
| HY-B0071A | Granisetron Hydrochloride | Antagonist | 99.90% | Unkown |
| HY-B0121 | Sumatriptan succinate | Agonist | 99.89% | Unkown |
| HY-B0206 | Rizatriptan benzoate | Agonist | 99.93% | Unkown |
| HY-B0366A | Cyproheptadine hydrochloride | Antagonist | 99.31% | Unkown |
| HY-A0095 | Flibanserin | Modulator | 99.9% | Unkown |
| HY-B0189A | Mosapride citrate | 99.96% | Yes | |
| HY-B0229 | Zolmitriptan | Agonist | 99.98% | Unkown |
| HY-B1110 | Nomifensine | Inhibitor | 98.93% | Unkown |
| HY-17410 | Iloperidone | Antagonist | 99.93% | Unkown |
| HY-A0095A | Flibanserin hydrochloride (propan-2-ol) hydrate | Modulator | 99.96% | Unkown |
| HY-B1396 | Nefazodone hydrochloride | Antagonist | 99.94% | Unkown |
| HY-14558 | Tandospirone | Agonist | 99.41% | Unkown |
| HY-A0010 | Eletriptan hydrobromide | Agonist | 99.33% | Unkown |
| HY-B0602 | Desvenlafaxine | Inhibitor | 99.76% | Unkown |
| HY-B0750 | Dolasetron | 99.90% | Unkown | |
| HY-B1154 | Penbutolol sulfate | Antagonist | 98.89% | Unkown |
| HY-B0740 | Cyclobenzaprine hydrochloride | 99.95% | Unkown | |
| HY-B0189 | Mosapride | 99.87% | Yes | |
| HY-B1110A | Nomifensine maleate | Inhibitor | 98.73% | Unkown |
| HY-19733 | Lumateperone tosylate | 99.78% | Unkown | |
| HY-B0072 | Tropisetron | 99.93% | Unkown | |
| HY-A0008 | Talipexole dihydrochloride | 99.31% | Unkown | |
| HY-W380450 | Viloxazine | 99.15% | Unkown | |
| HY-32329 | Setiptiline | 98.03% | Unkown | |
| HY-A0019A | Paliperidone palmitate | Antagonist | 99.93% | Unkown |
| HY-B0032 | Lurasidone Hydrochloride | 99.86% | Unkown | |
| HY-B0068 | Azasetron hydrochloride | Antagonist | 99.76% | Unkown |
| HY-A0075 | Decloxizine dihydrochloride | Antagonist | 99.69% | Unkown |
| HY-122537A | Arotinolol | Antagonist | 99.93% | Unkown |
| HY-17407 | Ziprasidone hydrochloride monohydrate | Antagonist | 98.11% | Unkown |
| HY-B0731A | Perospirone | 99.03% | Unkown | |
| HY-103093 | Zotepine | Antagonist | 99.80% | Unkown |
| HY-14539R | Clozapine (Standard) | 99.98% | Unkown | |
| HY-32329A | Setiptiline maleate | Antagonist | 99.94% | Unkown |
| HY-B0595 | Ramosetron Hydrochloride | Antagonist | 99.96% | Unkown |
| HY-B0020 | Tropisetron Hydrochloride | 99.97% | Unkown | |
| HY-B0602A | Desvenlafaxine succinate hydrate | Inhibitor | 99.82% | Unkown |
| HY-100562 | Flopropione | 99.97% | Unkown | |
| HY-125784 | Viloxazine hydrochloride | Inhibitor | 98.94% | Unkown |
| HY-B0197A | Naratriptan hydrochloride | Agonist | 99.69% | Unkown |
| HY-B0500 | Alverine citrate | Antagonist | 99.49% | Unkown |
| HY-14542A | Ziprasidone hydrochloride | Antagonist | 99.74% | Unkown |
| HY-17382A | Metoclopramide hydrochloride hydrate | Antagonist | 99.96% | Unkown |
| HY-70050A | Alosetron | Antagonist | 96.26% | Unkown |
| HY-B1658A | Frovatriptan succinate hydrate | Agonist | 99.91% | Unkown |
| HY-108256 | Melitracen hydrochloride | Inhibitor | 99.80% | Yes |
| HY-B0061 | Tandospirone citrate | Agonist | 99.92% | Unkown |
| HY-B0115 | Pizotifen | Antagonist | 99.63% | Unkown |
| HY-B0527AR | Amitriptyline hydrochloride (Standard) | 99.03% | Unkown | |
| HY-B1101A | Pimethixene maleate | Antagonist | 99.98% | Unkown |
| HY-B1473R | Serotonin hydrochloride (Standard) | 99.28% | Unkown | |
| HY-100703 | Pipamperone | Antagonist | 99.89% | Unkown |
| HY-103415 | Nemonapride | 99.90% | Unkown | |
| HY-B1107 | Naftidrofuryl oxalate | Antagonist | 99.94% | Unkown |
| HY-10457 | Velusetrag | Agonist | 99.49% | Yes |
| HY-12390 | Lofepramine | Inhibitor | 99.36% | Unkown |
| HY-14196 | Toloxatone | Inhibitor | 98.11% | Unkown |
| HY-17038A | Agomelatine hydrochloride | 99.98% | Yes | |
| HY-B0383A | Almotriptan | Agonist | 99.18% | Unkown |
| HY-B0407AS | Chlorpromazine-d6 hydrochloride | 99.9% | Unkown | |
| HY-B2169 | Melperone | 99.84% | Yes | |
| HY-B2065 | Scopolamine hydrochloride | Antagonist | 99.88% | Unkown |
| HY-10457A | Velusetrag hydrochloride | Agonist | 98.95% | Yes |
| HY-14539A | Clozapine hydrochloride | 99.83% | Yes | |
| HY-B0354A | Urapidil hydrochloride | 99.86% | Unkown | |
| HY-B0383 | Almotriptan malate | Agonist | 99.53% | Unkown |
| HY-122272R | Paroxetine (Standard) | 99.79% | Unkown | |
| HY-B0115A | Pizotifen malate | Antagonist | 99.04% | Unkown |
| HY-107370 | Atomoxetine | Inhibitor | 98.50% | Yes |
| HY-14541R | Olanzapine (Standard) | 99.98% | Unkown | |
| HY-B0196AR | Venlafaxine hydrochloride (Standard) | Inhibitor | 99.99% | Unkown |
| HY-A0040 | Talipexole | Agonist | 99.75% | Unkown |
| HY-14149A | Cisapride monohydrate | Agonist | 99.87% | Yes |
| HY-14546A | Aripiprazole monohydrate | Agonist | 99.83% | Yes |
| HY-B0352R | Mirtazapine (Standard) | Antagonist | 99.95% | Unkown |
| HY-B0716 | Urapidil | 99.30% | Unkown | |
| HY-B0731 | Perospirone hydrochloride | 99.94% | Unkown | |
| HY-B0982R | Pindolol (Standard) | Antagonist | 99.04% | Unkown |
| HY-B1517AR | Alprenolol hydrochloride (Standard) | Antagonist | 97.51% | Unkown |
| HY-B0354AR | Urapidil hydrochloride (Standard) | 99.98% | Unkown | |
| HY-17382B | Metoclopramide hydrochloride | Antagonist | 99.96% | Unkown |
| HY-14546S1 | Aripiprazole-d8-1 | Agonist | 99.86% | Unkown |
| HY-116790 | (-)-Penbutolol | Antagonist | 99.74% | Unkown |
| HY-14546R | Aripiprazole (Standard) | Agonist | 99.50% | Unkown |
| HY-15856 | cis-(Z)-Flupentixol dihydrochloride | Antagonist | / | Unkown |
| HY-B0197 | Naratriptan | Agonist | 99.81% | Unkown |
| HY-B0607R | Nitisinone (Standard) | 99.55% | Unkown | |
| HY-B0750B | Dolasetron Mesylate hydrate | Antagonist | 99.88% | Unkown |
| HY-B0991R | Amoxapine (Standard) | 99.97% | Unkown | |
| HY-B1287R | Citalopram hydrobromide (Standard) | 99.91% | Unkown | |
| HY-G0014B | Quetiapine sulfoxide hydrochloride | 96.92% | Unkown | |
| HY-11018A | Risperidone hydrochloride | / | Unkown | |
| HY-15394 | (Rac)-Rotigotine hydrochloride | 98.11% | Unkown | |
| HY-15414AR | Vortioxetine hydrobromide (Standard) | Inhibitor | 99.59% | Unkown |
| HY-17582 | Decloxizine | Antagonist | 99.80% | Unkown |
| HY-A0018 | Palonosetron | / | Unkown | |
| HY-B1101 | Pimethixene | Antagonist | / | Unkown |
| HY-G0014 | Quetiapine sulfoxide | / | Unkown | |
| HY-14542B | Ziprasidone mesylate trihydrate | Antagonist | / | Unkown |
| HY-B2073 | Clocapramine | Antagonist | / | Unkown |
| HY-13575A | Blonanserin dihydrochloride | Antagonist | / | Unkown |
| HY-100703A | Pipamperone dihydrochloride | Antagonist | / | Unkown |
| HY-10563 | Sarpogrelate | Antagonist | / | Unkown |
| HY-107370A | (Rac)-Atomoxetine hydrochloride | Control | / | Unkown |
| HY-108256R | Melitracen hydrochloride (Standard) | Inhibitor | / | Unkown |
| HY-11018R | Risperidone (Standard) | / | Unkown | |
| HY-121311 | Metrenperone | / | Unkown | |
| HY-121778 | Melitracen | Inhibitor | / | Unkown |
| HY-122537 | Arotinolol hydrochloride | / | Unkown | |
| HY-12390A | Lofepramine hydrochloride | Inhibitor | / | Unkown |
| HY-125784B | (S)-Viloxazine hydrochloride | Control | 99.90% | Unkown |
| HY-128386 | Cinitapride monotartrate | / | Unkown | |
| HY-14542C | Ziprasidone mesylate | Antagonist | / | Unkown |
| HY-15394A | (Rac)-Rotigotine | / | Unkown | |
| HY-15780A | Brexpiprazole hydrochloride | / | Unkown | |
| HY-16170 | Desvenlafaxine succinate | Inhibitor | / | Unkown |
| HY-16688B | RU 24969 hemisuccinate | Agonist | / | Unkown |
| HY-17390B | Loxapine hydrochloride | / | Unkown | |
| HY-70050CR | Alosetron Hydrochloride (Standard) | Antagonist | / | Unkown |
| HY-A0007R | Rotigotine Hydrochloride (Standard) | / | Unkown | |
| HY-A0039 | Eletriptan | Agonist | / | Unkown |
| HY-A0077A | Perphenazine dihydrochloride | / | Unkown | |
| HY-B0019 | Azasetron | / | Unkown | |
| HY-B0020R | Tropisetron Hydrochloride (Standard) | / | Unkown | |
| HY-B0071AR | Granisetron Hydrochloride (Standard) | Antagonist | / | Unkown |
| HY-B0121A | Sumatriptan hydrochloride | Agonist | / | Unkown |
| HY-B0121R | Sumatriptan succinate (Standard) | Agonist | / | Unkown |
| HY-B0206R | Rizatriptan benzoate (Standard) | Agonist | / | Unkown |
| HY-B0500A | Alverine | Antagonist | / | Unkown |
| HY-B0670 | Dihydroergotamine | Activator | / | Unkown |
| HY-B0750BR | Dolasetron Mesylate hydrate (Standard) | Antagonist | / | Unkown |
| HY-B0773 | Paroxetine mesylate | / | Unkown | |
| HY-B1115R | Buspirone hydrochloride (Standard) | / | Unkown | |
| HY-B1213A | Trimipramine | / | Unkown | |
| HY-B1562 | Bopindolol | / | Unkown | |
| HY-B1658 | Frovatriptan | Agonist | / | Unkown |
| HY-B1658B | Frovatriptan succinate | Agonist | / | Unkown |
| HY-B2073A | Clocapramine dihydrochloride hydrate | Antagonist | / | Unkown |
| HY-W018475 | Rizatriptan | Agonist | / | Unkown |
| HY-11018B | Risperidone mesylate | / | Unkown | |
| HY-17038B | Agomelatine (L(+)-Tartaric acid) | 99.94% | Yes | |
| HY-17410A | Iloperidone hydrochloride | Antagonist | / | Unkown |
| HY-17582R | Decloxizine (Standard) | Antagonist | / | Unkown |
| HY-70050 | Alosetron (Hydrochloride(1:X)) | Antagonist | / | Unkown |
| HY-70050B | Alosetron ((Z)-2-butenedioate) | Antagonist | / | Unkown |
| HY-A0075R | Decloxizine dihydrochloride (Standard) | Antagonist | / | Unkown |
| HY-A0139 | Thiothixene | Antagonist | / | Unkown |
| HY-B0750A | Dolasetron Mesylate | Antagonist | / | Unkown |
| HY-G0002 | Lurasidone metabolite 14326 | Antagonist | / | Unkown |
| HY-U00356 | Tertatolol | Antagonist | / | Unkown |
Clinical Phase
Bioactive Molecules
(195)
| Cat. No. | Product Name |
Effect
|
Purity |
Phase |
|---|---|---|---|---|
| HY-110053 | Tandospirone hydrochloride | Agonist | / | Phase 4 |
| HY-11018S2 | Risperidone-d6 | / | Phase 4 | |
| HY-14152 | Prucalopride hydrochloride | Agonist | / | Phase 4 |
| HY-B0500B | Alverine hydrochloride | Antagonist | / | Phase 4 |
| HY-14541A | Olanzapine hydrochloride | / | Phase 4 | |
| HY-14940 | Volinanserin | Antagonist | 99.62% | Phase 3 |
| HY-B2132 | Tryptamine | 99.89% | Phase 3 | |
| HY-10791 | Ritanserin | 99.68% | Phase 3 | |
| HY-14689 | Ecopipam hydrochloride | Antagonist | 99.46% | Phase 3 |
| HY-136109 | Ulotaront hydrochloride | Agonist | 99.89% | Phase 3 |
| HY-101250 | Glemanserin | Antagonist | 98.96% | Phase 3 |
| HY-14604 | Xaliproden hydrochloride | 98.40% | Phase 3 | |
| HY-19469 | Roluperidone | 99.86% | Phase 3 | |
| HY-109067A | Opiranserin hydrochloride | Antagonist | 99.62% | Phase 3 |
| HY-14690 | Ecopipam | Antagonist | 99.77% | Phase 3 |
| HY-100820 | Sarizotan | Agonist | 98.23% | Phase 3 |
| HY-14339 | Intepirdine | Antagonist | 99.02% | Phase 3 |
| HY-18600 | Azimilide | Inhibitor | 99.01% | Phase 3 |
| HY-18600A | Azimilide dihydrochloride | Inhibitor | 98.17% | Phase 3 |
| HY-10792A | Eplivanserin (mixture) | 99.68% | Phase 3 | |
| HY-109112 | Brilaroxazine | 98.82% | Phase 3 | |
| HY-14338A | Idalopirdine hydrochloride | Antagonist | 99.64% | Phase 3 |
| HY-B1541 | Bemesetron | Antagonist | 99.83% | Phase 3 |
| HY-105285 | Piromelatine | 99.70% | Phase 3 | |
| HY-110129 | Eplivanserin hemifumarate | Antagonist | 99.10% | Phase 3 |
| HY-119541 | Ampreloxetine | Inhibitor | / | Phase 3 |
| HY-121653 | Flesinoxan | Agonist | 99.88% | Phase 3 |
| HY-16728 | Rapastinel | 99.78% | Phase 3 | |
| HY-101630 | Deramciclane | Antagonist | 98.13% | Phase 3 |
| HY-109118A | Masupirdine mesylate | Antagonist | 99.62% | Phase 3 |
| HY-118557 | Iferanserin | Antagonist | 99.74% | Phase 3 |
| HY-119541A | Ampreloxetine TFA | 98.30% | Phase 3 | |
| HY-126068 | Esamisulpride | Antagonist | 99.04% | Phase 3 |
| HY-14958A | Pardoprunox hydrochloride | Agonist | 99.46% | Phase 3 |
| HY-110033 | Ecopipam hydrobromide | Antagonist | 99.0% | Phase 3 |
| HY-19742A | Lecozotan hydrochloride | Antagonist | 99.04% | Phase 3 |
| HY-14147 | Renzapride | Agonist | 98.36% | Phase 3 |
| HY-14547A | Bifeprunox mesylate | Agonist | 99.89% | Phase 3 |
| HY-14848 | Naluzotan | 98.05% | Phase 3 | |
| HY-19110 | RG-12915 | Antagonist | 97.45% | Phase 3 |
| HY-19650 | Pumosetrag Hydrochloride | Agonist | 99.77% | Phase 3 |
| HY-B2089 | Cinitapride | 98.24% | Phase 3 | |
| HY-16687 | Eltoprazine | Modulator | ≥95.0% | Phase 3 |
| HY-136109A | Ulotaront | Agonist | / | Phase 3 |
| HY-100820A | Sarizotan hydrochloride | Agonist | / | Phase 3 |
| HY-103109 | Melperone hydrochloride | / | Phase 3 | |
| HY-105082 | Avitriptan | Agonist | / | Phase 3 |
| HY-105699 | Napamezole | / | Phase 3 | |
| HY-105998 | AVN-211 | Antagonist | / | Phase 3 |
| HY-106865 | Mivazerol | / | Phase 3 | |
| HY-106874A | Delequamine hydrochloride | Antagonist | / | Phase 3 |
| HY-10792 | Eplivanserin | Antagonist | / | Phase 3 |
| HY-109067 | Opiranserin | Antagonist | / | Phase 3 |
| HY-109118 | Masupirdine free base | Antagonist | / | Phase 3 |
| HY-136109E | SEP-363856 mesylate | Agonist | / | Phase 3 |
| HY-14148 | Renzapride hydrochloride | / | Phase 3 | |
| HY-14547 | Bifeprunox | Agonist | / | Phase 3 |
| HY-14827 | Zicronapine | Antagonist | / | Phase 3 |
| HY-14827A | Zicronapine fumarate | Antagonist | / | Phase 3 |
| HY-16729 | Relenopride | Agonist | / | Phase 3 |
| HY-175540 | PDGFRα kinase-IN-2 | Inhibitor | / | Phase 3 |
| HY-G0003A | Milsaperidone | Antagonist | / | Phase 3 |
| HY-100820B | Sarizotan dihydrochloride | Agonist | / | Phase 3 |
| HY-101698 | Alniditan | Agonist | / | Phase 3 |
| HY-105034 | Tiospirone | Antagonist | / | Phase 3 |
| HY-119820 | Xaliproden free base | / | Phase 3 | |
| HY-14338 | Idalopirdine | Antagonist | / | Phase 3 |
| HY-14958 | Pardoprunox | Agonist | / | Phase 3 |
| HY-13734 | PX-12 | Inducer | 99.96% | Phase 2 |
| HY-14564A | GTS-21 dihydrochloride | 99.65% | Phase 2 | |
| HY-156601 | Bexicaserin | Agonist | 99.83% | Phase 2 |
| HY-100717 | HT-2157 | Antagonist | 98.0% | Phase 2 |
| HY-102064 | SR 57227A | Agonist | 99.86% | Phase 2 |
| HY-13041 | LX-1031 | Inhibitor | 99.14% | Phase 2 |
| HY-14325 | L-745870 | Antagonist | 99.92% | Phase 2 |
| HY-14472 | Tesofensine | Inhibitor | 99.35% | Phase 2 |
| HY-18099A | S1RA hydrochloride | Antagonist | 99.76% | Phase 2 |
| HY-111200 | Vabicaserin hydrochloride | Agonist | 99.47% | Phase 2 |
| HY-19889 | JNJ-18038683 | Antagonist | 98.31% | Phase 2 |
| HY-14785 | Befiradol | Agonist | 99.52% | Phase 2 |
| HY-18099 | S1RA | Antagonist | 98.96% | Phase 2 |
| HY-103107 | LY334370 | Agonist | 99.59% | Phase 2 |
| HY-106246 | Pruvanserin | Antagonist | 99.54% | Phase 2 |
| HY-15574 | Piboserod | Antagonist | 98.35% | Phase 2 |
| HY-101094 | Ocaperidone | 98.65% | Phase 2 | |
| HY-15472 | PRX-08066 | 97.46% | Phase 2 | |
| HY-100769 | Hypidone hydrochloride | Agonist | 99.73% | Phase 2 |
| HY-103131 | PNU-142633 | Agonist | 98.6% | Phase 2 |
| HY-10559 | Nelotanserin | Antagonist | 99.66% | Phase 2 |
| HY-101124 | Rodatristat ethyl | Inhibitor | 99.82% | Phase 2 |
| HY-16687A | Eltoprazine hydrochloride | Modulator | 99.25% | Phase 2 |
| HY-117046A | AVN-101 hydrochloride | 99.06% | Phase 2 | |
| HY-10560 | Temanogrel | Antagonist | 98.94% | Phase 2 |
| HY-12142 | Vofopitant | Antagonist | 99.82% | Phase 2 |
| HY-12714 | TDHL | 99.9% | Phase 2 | |
| HY-12959A | Repinotan hydrochloride | Agonist | 97.08% | Phase 2 |
| HY-116076 | S-15535 | Modulator | 99.82% | Phase 2 |
| HY-121920 | 25C-NBOH hydrochloride | Agonist | 99.9% | Phase 2 |
| HY-14348 | GSK163090 | Antagonist | 99.57% | Phase 2 |
| HY-101609 | Lesopitron dihydrochloride | Agonist | 98.0% | Phase 2 |
| HY-101709 | Ricasetron | Antagonist | 98.62% | Phase 2 |
| HY-102057 | Felcisetrag | Agonist | 99.94% | Phase 2 |
| HY-105201 | Fabesetron | Antagonist | 95.72% | Phase 2 |
| HY-109036 | Landipirdine | Antagonist | 99.80% | Phase 2 |
| HY-116594 | OPC-14523 free base | Agonist | / | Phase 2 |
| HY-12959 | Repinotan | Agonist | / | Phase 2 |
| HY-14431 | Cerlapirdine | Antagonist | 98.84% | Phase 2 |
| HY-14785A | Befiradol hydrochloride | Agonist | 99.93% | Phase 2 |
| HY-16729A | Relenopride hydrochloride | Agonist | 99.85% | Phase 2 |
| HY-U00373 | Revexepride | 99.84% | Phase 2 | |
| HY-W014208 | NGX-267 | Agonist | 99.17% | Phase 2 |
| HY-U00121 | Lintopride | Antagonist | 96.38% | Phase 2 |
| HY-168537 | LB-102 | Inhibitor | 98.75% | Phase 2 |
| HY-100426A | Osemozotan hydrochloride | Agonist | / | Phase 2 |
| HY-101208A | L-694247 TFA | Agonist | / | Phase 2 |
| HY-103115 | Pruvanserin hydrochloride | Antagonist | / | Phase 2 |
| HY-10347 | Alnespirone | Agonist | / | Phase 2 |
| HY-10351 | Robalzotan | Inhibitor | / | Phase 2 |
| HY-105277 | Amesergide | Antagonist | / | Phase 2 |
| HY-10560A | Temanogrel hydrochloride | Antagonist | / | Phase 2 |
| HY-106100 | Roxindole | / | Phase 2 | |
| HY-106136 | TIK-301 | / | Phase 2 | |
| HY-106245 | HT-0712 | Inhibitor | / | Phase 2 |
| HY-106324A | Sergolexole maleate | Antagonist | / | Phase 2 |
| HY-106379 | Lurosetron | Antagonist | / | Phase 2 |
| HY-106418A | SGB-1534 hydrochloride | Antagonist | / | Phase 2 |
| HY-106430 | Piclozotan | Agonist | / | Phase 2 |
| HY-106904 | Nexopamil | Antagonist | / | Phase 2 |
| HY-106909A | YM114 | Antagonist | / | Phase 2 |
| HY-106936 | Mazapertine | Antagonist | 99.37% | Phase 2 |
| HY-120810 | MCI-225 hydrate hydrochloride | Antagonist | / | Phase 2 |
| HY-121053 | Adatanserin | Modulator | / | Phase 2 |
| HY-121704 | SR 57227A free base | / | Phase 2 | |
| HY-123829 | LY2624803 | Inhibitor | / | Phase 2 |
| HY-13708 | SUN C5174 | Antagonist | / | Phase 2 |
| HY-139049 | NXN-188 | / | Phase 2 | |
| HY-14431A | Cerlapirdine hydrochloride | Antagonist | / | Phase 2 |
| HY-14564 | GTS-21 | Agonist | / | Phase 2 |
| HY-14757 | Trelanserin | Antagonist | / | Phase 2 |
| HY-15472A | PRX-08066 maleate | / | Phase 2 | |
| HY-16687B | Eltoprazine dihydrochloride | Modulator | / | Phase 2 |
| HY-19158 | Org 13011 | Agonist | / | Phase 2 |
| HY-19252 | GR-4991W93 | Agonist | / | Phase 2 |
| HY-19846 | VRX-03011 | Agonist | / | Phase 2 |
| HY-19889A | JNJ-18038683 free base | Antagonist | / | Phase 2 |
| HY-A0157B | Dimethothiazine hydrochloride | Antagonist | / | Phase 2 |
| HY-105109 | Cilansetron | Antagonist | 99.98% | Phase 2 |
| HY-105196 | DAT-582 | Antagonist | / | Phase 2 |
| HY-106437 | ELB-139 | Agonist | / | Phase 2 |
| HY-120464 | PF-05212377 | Inhibitor | / | Phase 2 |
| HY-15574A | Piboserod hydrochloride | Antagonist | / | Phase 2 |
| HY-169785 | 7-Methyl DMT | Agonist | / | Phase 2 |
| HY-19283 | DU125530 | Antagonist | / | Phase 2 |
| HY-N0737A | Harmine | Inhibitor | 99.97% | Phase 1 |
| HY-N0737 | Harmine hydrochloride | Inhibitor | 99.98% | Phase 1 |
| HY-135981 | CMS-121 | Inhibitor | 99.63% | Phase 1 |
| HY-159795 | Claturafenib | Inhibitor | 99.95% | Phase 1 |
| HY-15419A | RS-127445 | Antagonist | 99.95% | Phase 1 |
| HY-19863 | F-15599 | Agonist | 99.13% | Phase 1 |
| HY-14340 | WAY-181187 | Agonist | 98.83% | Phase 1 |
| HY-121301 | Amperozide | Antagonist | 99.10% | Phase 1 |
| HY-101185 | T808 | Ligand | 98.20% | Phase 1 |
| HY-116565 | Usmarapride | Modulator | 98.0% | Phase 1 |
| HY-118899 | XR5944 | 97.39% | Phase 1 | |
| HY-14782 | Adoprazine | 98.60% | Phase 1 | |
| HY-161511 | LPH-5 | Antagonist | 98.08% | Phase 1 |
| HY-111419 | DSP-1053 | 99.75% | Phase 1 | |
| HY-19946 | Eptapirone | Agonist | 99.91% | Phase 1 |
| HY-14559 | PRX-07034 hydrochloride | Antagonist | 98.97% | Phase 1 |
| HY-106407 | Beloxepin | 98.04% | Phase 1 | |
| HY-100171A | PRX933 | Agonist | / | Phase 1 |
| HY-106602 | Gevotroline | / | Phase 1 | |
| HY-106928 | U 93385 | Agonist | / | Phase 1 |
| HY-106943 | 1192U90 | / | Phase 1 | |
| HY-107125 | AVN-322 | Antagonist | / | Phase 1 |
| HY-108081 | GSK-958108 | Antagonist | / | Phase 1 |
| HY-111419A | DSP-1053 benzenesulfonate | / | Phase 1 | |
| HY-114232 | BVT-74316 | Antagonist | / | Phase 1 |
| HY-117799C | (±)-LY-426965 dihydrochloride | Control | / | Phase 1 |
| HY-123044 | Tedatioxetine | Antagonist | / | Phase 1 |
| HY-123807 | JNJ-5234801 | / | Phase 1 | |
| HY-145487A | 5-Hydroxy-6-methoxy (S)-duloxetine maleate | Inhibitor | / | Phase 1 |
| HY-14782A | Adoprazine hydrochloride | / | Phase 1 | |
| HY-18138 | PF-03382792 | Agonist | 99.58% | Phase 1 |
| HY-19297 | SB-247853 | Antagonist | / | Phase 1 |
| HY-19372 | SSR-181507 hydrochloride | / | Phase 1 | |
| HY-19946A | Eptapirone fumarate | Agonist | / | Phase 1 |
| HY-W040555 | Norquetiapine dihydrochloride | 99.91% | Phase 1 | |
| HY-101619 | Abaperidone | Antagonist | / | Phase 1 |
| HY-116878 | 25B-NBOH hydrochloride | / | Phase 1 | |
| HY-119946 | BF-1 | Inhibitor | / | Phase 1 |
| HY-14287 | KW-5092 (fumarete) | / | Phase 1 | |
| HY-169114 | Goxalapladib | / | Phase 1 | |
| HY-19136 | WAY-100289 | Antagonist | / | Phase 1 |
| HY-19692 | Itasetron | Antagonist | / | Phase 1 |
Pre-clinical Phase
Bioactive Molecules
(1334)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-100579 | Ferrostatin-1 | Inhibitor | 99.96% | Unkown |
| HY-19545A | SCH-23390 hydrochloride | 99.83% | Unkown | |
| HY-12560A | PNU-282987 | 99.93% | Unkown | |
| HY-10349 | WAY-100635 | 99.97% | Unkown | |
| HY-112061 | 8-OH-DPAT | Agonist | 99.87% | Unkown |
| HY-N6771 | Cyclopiazonic acid | 99.86% | Unkown | |
| HY-12855A | Lys05 | Inhibitor | 99.74% | Unkown |
| HY-P1237 | C-Type Natriuretic Peptide (CNP) (1-22), human | Inhibitor | 99.84% | Unkown |
| HY-103124 | DOI hydrochloride | Agonist | 99.61% | Unkown |
| HY-101456 | PCPA methyl ester hydrochloride | Inhibitor | 99.89% | Unkown |
| HY-101369 | BW-723C86 | Agonist | 99.74% | Unkown |
| HY-15370A | SB-269970 hydrochloride | Antagonist | 99.67% | Unkown |
| HY-156562A | 5-PT formic | 99.91% | Unkown | |
| HY-10895 | SB-334867 | Antagonist | 99.48% | Unkown |
| HY-13409 | SB 242084 | Antagonist | 99.96% | Unkown |
| HY-103152 | GR 113808 | Antagonist | 99.96% | Unkown |
| HY-100753 | STAT3-IN-1 | 96.28% | Unkown | |
| HY-103153 | SB 204741 | Antagonist | 99.85% | Unkown |
| HY-N0049 | Nuciferine | 99.90% | Unkown | |
| HY-139206 | LY3509754 | Inhibitor | 99.35% | Unkown |
| HY-10349A | WAY-100635 maleate | 99.57% | Unkown | |
| HY-B1473AS | Serotonin-d4 | 99.61% | Unkown | |
| HY-107613 | R 59-022 | 99.82% | Unkown | |
| HY-145669 | DIF-3 | 99.84% | Unkown | |
| HY-15419 | RS-127445 hydrochloride | Antagonist | 99.78% | Unkown |
| HY-101524 | TC13172 | Inhibitor | 99.04% | Unkown |
| HY-107836 | Methiothepin mesylate | Antagonist | 99.36% | Unkown |
| HY-14444 | Plinabulin | 98.0% | Yes | |
| HY-N1957 | Gamma-Mangostin | 99.91% | Unkown | |
| HY-W001160 | 5-Hydroxyindole | Activator | 99.94% | Unkown |
| HY-159520 | Ofirnoflastum | 99.93% | Unkown | |
| HY-172420 | Bretisilocin | Agonist | 99.69% | Unkown |
| HY-103413 | Eticlopride hydrochloride | Antagonist | 99.45% | Unkown |
| HY-15688 | 8-OH-DPAT hydrobromide | Agonist | 99.88% | Unkown |
| HY-P10761 | DPI-4452 | Modulator | 99.30% | Unkown |
| HY-Y1191 | EEDQ | Antagonist | 99.97% | Unkown |
| HY-101105A | SB-224289 hydrochloride | Antagonist | 99.0% | Unkown |
| HY-103100 | SB-699551 | 99.53% | Unkown | |
| HY-136420 | SJF-0628 | 99.90% | Unkown | |
| HY-149302 | MC4033 | 98.26% | Unkown | |
| HY-50908 | Ridaforolimus | 99.75% | Unkown | |
| HY-15370 | SB-269970 | Antagonist | 98.78% | Unkown |
| HY-19358 | 2-Methyl-5-HT | Agonist | 98.93% | Unkown |
| HY-153698 | CC-3060 | 99.7% | Unkown | |
| HY-N0740 | Jatrorrhizine chloride | Inhibitor | 99.82% | Unkown |
| HY-B1473S | Serotonin-d4 hydrochloride | 99.48% | Unkown | |
| HY-111455 | LP-211 | Agonist | 99.87% | Unkown |
| HY-100554 | BMY 7378 | 99.92% | Unkown | |
| HY-123630 | Allura Red AC | 99.00% | Unkown | |
| HY-103430A | SKF-83566 | Antagonist | 99.86% | Unkown |
| HY-100938 | m-CPBG hydrochloride | Agonist | 99.85% | Unkown |
| HY-101341 | RS 67333 hydrochloride | Agonist | 99.68% | Unkown |
| HY-105670 | PHA-543613 | Agonist | 99.95% | Unkown |
| HY-16688 | RU 24969 | Agonist | 99.77% | Unkown |
| HY-103151 | CP94253 hydrochloride | Agonist | 98.00% | Unkown |
| HY-30152 | Xanthotoxol | Antagonist | 99.46% | Unkown |
| HY-P1422 | Spadin | 99.84% | Unkown | |
| HY-W015169 | 5-Methoxytryptamine | Agonist | 99.91% | Unkown |
| HY-103102 | TCB2 | Agonist | 99.21% | Unkown |
| HY-107664 | SR 142948 | Antagonist | 99.27% | Unkown |
| HY-121675 | 2-Bromo-LSD | 97.26% | Unkown | |
| HY-169841 | IHCH-7086 | Agonist | 98.96% | Unkown |
| HY-75564 | Cyclo(Ala-Gly) | 95.84% | Unkown | |
| HY-120528A | GB-110 hydrochloride | Agonist | 99.86% | Unkown |
| HY-130602 | MS432 | Degrader | 99.72% | Unkown |
| HY-101365A | RS-102221 hydrochloride | Antagonist | 98.03% | Unkown |
| HY-112390A | Syk Inhibitor II | Inhibitor | 98.15% | Unkown |
| HY-13788 | LY 344864 | Agonist | 98.59% | Unkown |
| HY-N2125 | Parishin C | Agonist | 99.24% | Unkown |
| HY-103138A | (Rac)-WAY-161503 | Agonist | 98.49% | Unkown |
| HY-10847B | SB-277011 hydrochloride | Antagonist | 99.59% | Unkown |
| HY-100665 | Dehydroaripiprazole | Agonist | 99.95% | Unkown |
| HY-103156 | NAS-181 dimesylate | Antagonist | 96.37% | Unkown |
| HY-13409A | SB 242084 dihydrochloride | Antagonist | 98.12% | Unkown |
| HY-103387 | DuP-697 | 99.79% | Unkown | |
| HY-13221 | BRL 54443 | Agonist | 98.97% | Unkown |
| HY-149236 | PROTAC GPX4 degrader-1 | 98.53% | Unkown | |
| HY-P1237A | C-Type Natriuretic Peptide (CNP) (1-22), human TFA | 99.07% | Unkown | |
| HY-U00443 | SB 258719 | Antagonist | 99.94% | Unkown |
| HY-14336A | SB 271046 Hydrochloride | Antagonist | 99.93% | Unkown |
| HY-100794 | GR127935 hydrochloride | Antagonist | 99.38% | Unkown |
| HY-113254 | 13,14-Dihydro-15-keto-PGE2 | 96.75% | Unkown | |
| HY-14325B | L-745870 hydrochloride | Antagonist | 99.91% | Unkown |
| HY-W052508 | Norquetiapine | 99.95% | Unkown | |
| HY-W131725 | (+)-Norfenfluramine | Agonist | 98.79% | Unkown |
| HY-136674 | Aftin-5 | Inducer | 99.70% | Unkown |
| HY-103101 | LP44 hydrochloride | Agonist | 98.12% | Unkown |
| HY-118010A | (+)-Norfenfluramine hydrochloride | Agonist | 99.77% | Unkown |
| HY-19818A | NAN-190 hydrobromide | Antagonist | 98.15% | Unkown |
| HY-N6002 | 3'-Hydroxypterostilbene | Inducer | 99.89% | Unkown |
| HY-W028142 | Quipazine | 97.0% | Unkown | |
| HY-101331 | Phenylbiguanide | Agonist | 98.0% | Unkown |
| HY-103142 | AS19 | Agonist | 99.69% | Unkown |
| HY-113008A | cis-Urocanic acid | Agonist | 99.92% | Unkown |
| HY-122422A | Gepirone hydrochloride | Agonist | 99.88% | Unkown |
| HY-P1435 | NoxA1ds | Inhibitor | 95.34% | Unkown |
| HY-103137 | Zacopride hydrochloride | 99.69% | Unkown | |
| HY-136621 | 5-HT1A modulator 2 hydrochloride | Modulator | 99.69% | Unkown |
| HY-B1371A | Spiperone hydrochloride | 99.10% | Unkown | |
| HY-P3641A | Kisspeptin 13 TFA | Activator | 98.91% | Unkown |
| HY-N8439 | Questiomycin A | 99.00% | Unkown | |
| HY-100851A | LY-272015 hydrochloride | Antagonist | 99.89% | Unkown |
| HY-100942 | 5-Carboxamidotryptamine maleate | Agonist | 99.73% | Unkown |
| HY-101222 | SB-203186 hydrochloride | Antagonist | 99.94% | Unkown |
| HY-124591 | TC-2153 | Inhibitor | 98.19% | Unkown |
| HY-15543A | CP-809101 hydrochloride | Agonist | 98.61% | Unkown |
| HY-159831 | Remlifanserin | Agonist | 98.29% | Unkown |
| HY-18137 | PF-04995274 | Agonist | 99.75% | Unkown |
| HY-P1422A | Spadin TFA | 99.73% | Unkown | |
| HY-10895A | SB-334867 free base | Antagonist | 99.88% | Unkown |
| HY-101357A | CP 93129 dihydrochloride | Agonist | 98.01% | Unkown |
| HY-103099 | SB-399885 hydrochloride | Antagonist | 98.33% | Unkown |
| HY-103112B | SB 243213 | Antagonist | 99.39% | Unkown |
| HY-103149 | SB-216641A | Antagonist | 98.04% | Unkown |
| HY-106100A | Roxindole hydrochloride | 99.48% | Unkown | |
| HY-120553 | B-355252 | Inhibitor | 99.71% | Unkown |
| HY-153383 | PDCD4-IN-1 | Inhibitor | 99.41% | Unkown |
| HY-16728B | Rapastinel Trifluoroacetate | 98.0% | Unkown | |
| HY-W050162 | (E)-3,4,5-Trimethoxycinnamic acid | 99.90% | Unkown | |
| HY-100656 | Desmethyl cariprazine | Antagonist | 98.08% | Unkown |
| HY-119156 | Altanserin | 99.93% | Unkown | |
| HY-12143 | Vofopitant dihydrochloride | Antagonist | 99.56% | Unkown |
| HY-13200 | BRL-15572 dihydrochloride | Antagonist | 99.79% | Unkown |
| HY-145393 | 5-HT2A receptor agonist-1 | Agonist | 99.94% | Unkown |
| HY-147276 | Izuforant | Antagonist | 98.88% | Unkown |
| HY-153912 | 5-HT2A receptor agonist-3 | Agonist | 98.53% | Unkown |
| HY-75813 | 2-Aminonicotinaldehyde | 99.98% | Unkown | |
| HY-P2624A | st-Ht31 ammonium | Inhibitor | 96.61% | Unkown |
| HY-W010869 | GR 55562 hydrochloride | Antagonist | 98.0% | Unkown |
| HY-W077477 | IHCH-7113 | Agonist | 98.26% | Unkown |
| HY-100606 | l-Pindolol | 99.89% | Unkown | |
| HY-101248 | GR-46611 | Agonist | 99.86% | Unkown |
| HY-101324A | MK-212 monohydrochloride | Agonist | 99.69% | Yes |
| HY-103129 | SB-200646A | Antagonist | 99.14% | Unkown |
| HY-110023 | Zimelidine dihydrochloride | Inhibitor | 98.08% | Unkown |
| HY-119677 | Oxypertine | 99.84% | Unkown | |
| HY-121392 | GR 125743 | Antagonist | 99.77% | Unkown |
| HY-123838 | Ro60-0175 | Agonist | 99.52% | Unkown |
| HY-123869 | GR127935 | Antagonist | 99.33% | Unkown |
| HY-12697 | NGB 2904 | Antagonist | 99.76% | Unkown |
| HY-147348 | 4-Formylcolchicine | 99.84% | Unkown | |
| HY-N0749A | Jatrorrhizine hydroxide | Inhibitor | 98.06% | Unkown |
| HY-W015169A | 5-Methoxytryptamine hydrochloride | Agonist | 99.55% | Unkown |
| HY-101198 | Clobenpropit dihydrobromide | 99.76% | Unkown | |
| HY-101172 | RS 23597-190 | Antagonist | 99.81% | Unkown |
| HY-103118 | PU02 | 99.76% | Unkown | |
| HY-103212A | Azepexole hydrochloride | Agonist | 99.89% | Unkown |
| HY-103524 | Valerenic acid | 99.95% | Unkown | |
| HY-106157 | Donitriptan | Agonist | 98.06% | Unkown |
| HY-106587A | Octoclothepin maleate salt | 99.14% | Unkown | |
| HY-126779 | Stictic acid | 98.5% | Unkown | |
| HY-128901 | F 13714 fumarate | Agonist | 99.05% | Unkown |
| HY-132225 | SB 206553 | Agonist | 99.35% | Unkown |
| HY-14763S1 | Cariprazine-d8 | Modulator | 98.77% | Unkown |
| HY-156601A | (S)-Bexicaserin | Agonist | 99.93% | Unkown |
| HY-N0247 | Saikosaponin B1 | Inhibitor | 99.42% | Unkown |
| HY-N2411 | Geissoschizine methyl ether | Agonist | 99.97% | Unkown |
| HY-N8225 | Manassantin B | 98.49% | Unkown | |
| HY-W795507 | Cyanopindolol | Antagonist | 99.24% | Unkown |
| HY-100993 | α-Methylserotonin maleate | Agonist | 99.9% | Unkown |
| HY-G0014A | Quetiapine sulfoxide dihydrochloride | 98.63% | Unkown | |
| HY-N0775 | Isocorynoxeine | Inhibitor | 99.52% | Unkown |
| HY-W017424 | 2-Aminobenzothiazole | 99.74% | Unkown | |
| HY-157516 | CDK2-IN-22 | Inhibitor | 98.64% | Unkown |
| HY-100218B | (1R,3S)-RSL3 | Control | 99.78% | Unkown |
| HY-100658 | Didesmethyl cariprazine | 99.63% | Unkown | |
| HY-100943 | Cinanserin hydrochloride | 99.48% | Unkown | |
| HY-103094 | LY266097 hydrochloride | Inhibitor | 98.41% | Unkown |
| HY-103136 | R-96544 | Antagonist | 99.50% | Unkown |
| HY-103428 | LE 300 | Antagonist | 98.5% | Unkown |
| HY-105896 | SB399885 | Antagonist | 98.85% | Unkown |
| HY-110289 | (R)-Citalopram oxalate | Inhibitor | 99.52% | Unkown |
| HY-118824A | N-Feruloylserotonin | Inhibitor | 99.93% | Unkown |
| HY-124501 | LY 165163 | Agonist | 98.12% | Unkown |
| HY-124821 | VA012 | Modulator | 99.34% | Unkown |
| HY-12706 | Spiroxatrine | Antagonist | 99.25% | Unkown |
| HY-131678 | Palmitoyl serotonin | Antagonist | 99.9% | Unkown |
| HY-133113 | 7-Desmethyl-agomelatine | Antagonist | 99.89% | Unkown |
| HY-133887 | Methotrexate α-tert-butyl ester | Inhibitor | 97.38% | Unkown |
| HY-134807 | Indophagolin | 98.05% | Unkown | |
| HY-13527 | LY310762 | Antagonist | 98.89% | Unkown |
| HY-14264 | Cyamemazine | Antagonist | 99.47% | Unkown |
| HY-14546S | Aripiprazole-d8 | Agonist | 98.35% | Unkown |
| HY-15780S | Brexpiprazole-d8 | 99.0% | Unkown | |
| HY-16688A | RU 24969 succinate | Agonist | 99.58% | Unkown |
| HY-169229 | GM-60186 | Inhibitor | 99.34% | Unkown |
| HY-19686 | Ipsapirone | Modulator | 99.45% | Unkown |
| HY-59201A | A-582941 dihydrochloride | 99.78% | Unkown | |
| HY-B0002BS | Ondansetron-d5 | Antagonist | 99.95% | Unkown |
| HY-B1737 | Pirenperone | Antagonist | 98.97% | Unkown |
| HY-D2335 | SERTlight | 99.73% | Unkown | |
| HY-101331A | Phenylbiguanide hydrochloride | Agonist | 99.96% | Unkown |
| HY-125641 | AL-34662 | Agonist | 99.20% | Unkown |
| HY-15780S1 | Brexpiprazole-d8-1 | 96.48% | Unkown | |
| HY-111844 | PROTAC RAR Degrader-1 | Inhibitor | 97.91% | Unkown |
| HY-120083 | Rodatristat | Inhibitor | 98.41% | Unkown |
| HY-14541S | Olanzapine-d3 | 99.78% | Unkown | |
| HY-B0196S | Venlafaxine-d6 | Inhibitor | 98.55% | Unkown |
| HY-B0527AS | Amitriptyline-d6 hydrochloride | 99.93% | Unkown | |
| HY-100170 | 5-HT4 antagonist 1 | Antagonist | 98.95% | Unkown |
| HY-100330 | YM348 | Agonist | 98.89% | Unkown |
| HY-101046 | Quipazine dimaleate | 99.96% | Unkown | |
| HY-103135 | SB 206553 hydrochloride | Antagonist | 99.36% | Unkown |
| HY-103138 | (Rac)-WAY-161503 hydrochloride | Agonist | 99.5% | Unkown |
| HY-108057A | Facinicline hydrochloride | 99.66% | Unkown | |
| HY-117575A | WAY-100135 dihydrochloride | Antagonist | 98.14% | Unkown |
| HY-118301 | ADX71441 | 98.63% | Unkown | |
| HY-120738 | p-MPPI hydrochloride | Antagonist | 99.70% | Unkown |
| HY-121826 | Naronapride | Agonist | 99.79% | Unkown |
| HY-133111S | 3-Hydroxy agomelatine-d3 | Antagonist | 99.69% | Unkown |
| HY-147203 | 5-HT2B antagonist-1 | Antagonist | 99.90% | Unkown |
| HY-14763S | Cariprazine-d6 | Modulator | 98.74% | Unkown |
| HY-155672 | JPC0323 | Modulator | 99.5% | Unkown |
| HY-161247 | 5-HT2A antagonist 2 | Antagonist | 98.90% | Unkown |
| HY-167902 | YM-31636 free base | Agonist | 99.05% | Unkown |
| HY-169652 | NPC26 | Activator | 98.0% | Unkown |
| HY-175231 | ST171 | Agonist | 99.34% | Unkown |
| HY-19026 | Siguazodan | Inhibitor | 99.06% | Unkown |
| HY-19477 | SB-616234-A | Antagonist | 99.40% | Unkown |
| HY-B0031S1 | Quetiapine-d4 hemifumarate | 99.77% | Unkown | |
| HY-B1562B | Bopindolol malonate | 98.30% | Unkown | |
| HY-N3057 | Pinostrobin chalcone | 99.94% | Unkown | |
| HY-N9596 | Stigmasta-4,22-dien-3-one | Inhibitor | 98.82% | Unkown |
| HY-W1130456 | Lipid TD5 | 99.19% | Unkown | |
| HY-100656AS | Desmethyl cariprazine-d8 | 99.93% | Unkown | |
| HY-100658S | Didesmethyl cariprazine-d8 | 99.44% | Unkown | |
| HY-113008AS | cis-Urocanic acid-13C3 | Agonist | 99.46% | Unkown |
| HY-13620 | Elinafide | Inhibitor | 98.02% | Unkown |
| HY-34763 | 7-Hydroxycarbostyril | 99.05% | Unkown | |
| HY-B1870 | Metaldehyde | 98.0% | Unkown | |
| HY-N0737AG | Harmine (GMP) | Inhibitor | / | Unkown |
| HY-162677 | MT-1207 | Antagonist | 99.96% | Unkown |
| HY-101924 | AVN-492 | Antagonist | 99.30% | Unkown |
| HY-176772 | QHL-1618 | / | Unkown | |
| HY-109167 | Aramisulpride | Antagonist | 98.49% | Unkown |
| HY-100923 | H-9 Dihydrochloride | Inhibitor | 98.98% | Unkown |
| HY-101100 | Anpirtoline hydrochloride | Agonist | 99.86% | Unkown |
| HY-101698B | Alniditan dihydrochloride | Agonist | 99.70% | Unkown |
| HY-103133 | WAY208466 dihydrochloride | Agonist | 98.43% | Unkown |
| HY-103141 | SB-258585 hydrochloride | 99.72% | Unkown | |
| HY-103337 | N-Arachidonoylserotonin | 99.11% | Unkown | |
| HY-105090 | Lerisetron | Antagonist | 99.69% | Unkown |
| HY-106617 | Etoperidone | / | Unkown | |
| HY-107664A | SR 142948 dihydrochloride | Antagonist | 99.07% | Unkown |
| HY-108509 | BMY-14802 hydrochloride | 98.02% | Unkown | |
| HY-110094 | BIMU 8 | Agonist | 99.60% | Unkown |
| HY-116594A | OPC-14523 hydrochloride | 99.95% | Unkown | |
| HY-118796 | 4-Hydroxy MET | Agonist | 99.30% | Unkown |
| HY-119061 | SB357134 | Antagonist | 99.4% | Unkown |
| HY-121208 | Ketanserinol | Antagonist | 98.05% | Unkown |
| HY-121675A | 2-Bromo-LSD D-Tartrate | 99.91% | Unkown | |
| HY-12537 | Peptide 401 | Antagonist | 97.37% | Unkown |
| HY-126057S | (R)-Praziquantel-d11 | 99.57% | Unkown | |
| HY-133111 | 3-Hydroxy agomelatine | Antagonist | 99.13% | Unkown |
| HY-133152S | Brexpiprazole S-oxide-d8 | 98.72% | Unkown | |
| HY-135555 | 5-Carboxamidotryptamine | Agonist | 98.74% | Unkown |
| HY-136281 | DuP 734 | Antagonist | 98.82% | Unkown |
| HY-137572 | (R)-DOI hydrochloride | Agonist | 99.63% | Unkown |
| HY-139201E | Poly-D-lysine hydrobromide (MW 150000-300000) | / | Unkown | |
| HY-145463 | α-Methylserotonin | Agonist | / | Unkown |
| HY-153091 | BMY 14802 | 98.07% | Unkown | |
| HY-160811 | hVEGF-IN-3 | Inhibitor | 99.56% | Unkown |
| HY-164703 | Lumateperone metabolite 1 | Control | 98.26% | Unkown |
| HY-19199 | E-3620 | Antagonist | 98.88% | Unkown |
| HY-19950 | 5-HT2A receptor agonist-6 | Agonist | 99.79% | Unkown |
| HY-B0031R | Quetiapine hemifumarate (Standard) | 99.87% | Unkown | |
| HY-B0102C | (R)-Fluoxetine hydrochloride | Inhibitor | 99.82% | Unkown |
| HY-B0196AS1 | Venlafaxine-d6 hydrochloride | Inhibitor | 98.18% | Unkown |
| HY-B0740R | Cyclobenzaprine hydrochloride (Standard) | Antagonist | 99.99% | Unkown |
| HY-N1414 | (E)-3',6-Disinapoylsucrose | 99.59% | Unkown | |
| HY-P1303 | CART(62-76)(human,rat) | Inhibitor | 96.24% | Unkown |
| HY-P1441A | Mambalgin 1 TFA | Inhibitor | 95.72% | Unkown |
| HY-W009754 | Antidepressant agent 10 | Inhibitor | 99.96% | Unkown |
| HY-14940S | Volinanserin-d4 hydrochloride | Antagonist | 98.62% | Unkown |
| HY-N3398 | Lauroscholtzine | Agonist | 99.81% | Unkown |
| HY-N8200 | Cassiaside B2 | 99.68% | Unkown | |
| HY-W010892S | Scopolamine-d3 hydrobromide | Antagonist | 98.01% | Unkown |
| HY-W016194 | 1-(Carboxymethyl)cyclohexanecarboxylic acid | 95.0% | Unkown | |
| HY-W017355 | 4-Hydroxythiobenzamide | / | Unkown | |
| HY-B0031S | Quetiapine-d4 fumarate | ≥98.0% | Unkown | |
| HY-103089 | LY393558 | Antagonist | 99.0% | Unkown |
| HY-133869 | cGMP-HTL | Inducer | 99.71% | Unkown |
| HY-116565A | Usmarapride free base | Agonist | 99.91% | Unkown |
| HY-110232 | Risperidone-d4 | 99.34% | Unkown | |
| HY-135096 | Amitriptyline-d3 hydrochloride | 99.75% | Unkown | |
| HY-B1714 | NSC 601980 analog | 98.0% | Unkown | |
| HY-100166 | AP521 | Agonist | 98.96% | Unkown |
| HY-100243 | (+)-Norcisapride | Modulator | 99.32% | Unkown |
| HY-100290 | 5-HT1A modulator 1 | Modulator | 97.12% | Unkown |
| HY-100552 | VUF10166 | Antagonist | 99.83% | Unkown |
| HY-100970 | 4F 4PP oxalate | Antagonist | 98.86% | Unkown |
| HY-100971 | Spiramide | Antagonist | 99.23% | Unkown |
| HY-101343 | RS 39604 | Antagonist | 98.0% | Unkown |
| HY-101367A | GR 55562 dihydrochloride | Antagonist | 99.0% | Unkown |
| HY-101377A | R(+)-8-OH-DPAT hydrobromide | Agonist | 99.30% | Unkown |
| HY-101755 | Tedatioxetine hydrobromide | Antagonist | 99.83% | Unkown |
| HY-101815 | Lidanserin | Antagonist | ≥98.0% | Unkown |
| HY-103090 | NPS ALX Compound 4a | Antagonist | ≥99.0% | Unkown |
| HY-103104 | Fananserin | Antagonist | 99.97% | Unkown |
| HY-103105A | LP 12 hydrochloride hydrate | Agonist | 99.0% | Unkown |
| HY-103107B | LY334370 fumarate | Agonist | / | Unkown |
| HY-103108 | CJ033466 | Agonist | 98.29% | Unkown |
| HY-103110 | ST1936 | Agonist | 98.66% | Unkown |
| HY-103112 | SB 243213 hydrochloride | Antagonist | 98.84% | Unkown |
| HY-103112A | SB 243213 dihydrochloride | Antagonist | ≥99.0% | Unkown |
| HY-103130 | EMD386088 | Agonist | 99.06% | Unkown |
| HY-103140 | Ro60-0175 fumarate | Agonist | 99.47% | Unkown |
| HY-103145 | PNU-22394 hydrochloride | Agonist | 98.79% | Unkown |
| HY-103147 | Mesulergine hydrochloride | / | Unkown | |
| HY-103154 | SB228357 | Antagonist | 99.43% | Unkown |
| HY-103430 | SKF-83566 hydrobromide | Antagonist | / | Unkown |
| HY-10351A | Robalzotan hydrochloride | Inhibitor | 99.5% | Unkown |
| HY-106584 | Mosapramine | Antagonist | 98.58% | Unkown |
| HY-106587 | Octoclothepine | 99.90% | Unkown | |
| HY-107128 | Ampreloxetine hydrochloride | Inhibitor | 99.43% | Unkown |
| HY-107613A | R 59-022 hydrochloride | 98.88% | Unkown | |
| HY-10847A | SB-277011 dihydrochloride | Antagonist | / | Unkown |
| HY-10861 | D3/5-HT receptor modulator-1 | 99.75% | Unkown | |
| HY-110001 | (S)-WAY 100135 dihydrochloride | Antagonist | 99.9% | Unkown |
| HY-110024 | S-14506 hydrochloride | 98.64% | Unkown | |
| HY-112390 | Syk Inhibitor II dihydrochloride | Inhibitor | / | Unkown |
| HY-116941 | A-381393 | Antagonist | 99.92% | Unkown |
| HY-118152 | Org-12962 | Agonist | 99.93% | Unkown |
| HY-120528 | GB-110 | Agonist | / | Unkown |
| HY-121199 | Germanicol | Inducer | 99.0% | Unkown |
| HY-121458 | Nemorosone | Inducer | 99.0% | Unkown |
| HY-122675 | ACG416B | Inhibitor | 98.99% | Unkown |
| HY-12709 | ARC 239 | 99.71% | Unkown | |
| HY-129101 | (-)-Eseroline fumarate | Antagonist | 98.03% | Unkown |
| HY-131255 | Ziprasidone amino acid | Antagonist | 99.46% | Unkown |
| HY-131397 | Docosahexaenoyl serotonin | Inhibitor | 99.0% | Unkown |
| HY-133024 | Flumexadol | Agonist | 99.86% | Unkown |
| HY-133152 | Brexpiprazole S-oxide | 96.51% | Unkown | |
| HY-133858 | 25N-NBOMe hydrochloride | Agonist | 99.9% | Unkown |
| HY-135392 | N-Desmethyl Pimavanserin | 98.88% | Unkown | |
| HY-137332 | N-Methylspiroperidol | Antagonist | / | Unkown |
| HY-13788C | LY 344864 racemate | Agonist | 98.07% | Unkown |
| HY-141422A | 4,4-Diphenylbutylamine hydrochloride | Antagonist | 99.00% | Unkown |
| HY-14261S | Vilazodone-d8 | Inhibitor | 99.0% | Unkown |
| HY-14441 | ML 10302 | Agonist | 98.95% | Unkown |
| HY-14848A | Naluzotan hydrochloride | 99.63% | Unkown | |
| HY-14940A | (S)-Volinanserin | Antagonist | 99.84% | Unkown |
| HY-149763 | Aβ42 agonist-1 | 99.90% | Unkown | |
| HY-149764 | Aβ42 agonist-2 | 99.92% | Unkown | |
| HY-151596 | MAO-A/5-HT2AR-IN-1 | Inhibitor | 99.71% | Unkown |
| HY-15394S1 | (Rac)-Rotigotine-d3 hydrochloride | 98.05% | Unkown | |
| HY-15401 | WAY 163909 | Agonist | / | Unkown |
| HY-156375 | PKM2 activator 6 | / | Unkown | |
| HY-156532 | 5-HT2C agonist-3 | Agonist | 99.86% | Unkown |
| HY-156532C | (-)-5-HT2C agonist-3 | Agonist | / | Unkown |
| HY-157740 | XSJ-10 | Inhibitor | 95.16% | Unkown |
| HY-160887 | FPT | Agonist | 98.06% | Unkown |
| HY-160921 | Capeserod | Agonist | 98.66% | Unkown |
| HY-162074 | Nipamovir | Inhibitor | 98.60% | Unkown |
| HY-164350 | KRAS inhibitor-27 | Inhibitor | 98.27% | Unkown |
| HY-168093 | Cetzole | Inducer | / | Unkown |
| HY-169938 | LSD1/HDAC-IN-2 | / | Unkown | |
| HY-17038S2 | Agomelatine-d3 | 98.0% | Unkown | |
| HY-173029 | UAMC-4821 | Inhibitor | 98.01% | Unkown |
| HY-178907 | SERT/5-HT-IN-1 | Inhibitor | / | Unkown |
| HY-179579 | TMU4142 | Agonist | 98.93% | Unkown |
| HY-180895 | Y207–5465 | Inhibitor | / | Unkown |
| HY-185345 | GR119566X | Ligand | / | Unkown |
| HY-19134 | EMD 56551 | Agonist | / | Unkown |
| HY-402805 | DYRK2-IN-2 | Inhibitor | / | Unkown |
| HY-A0077S1 | Perphenazine-d4 | 98.83% | Unkown | |
| HY-A0160 | Indalpine | Inhibitor | / | Unkown |
| HY-B0002S | Ondansetron-d3 hydrochloride | Antagonist | 98.78% | Unkown |
| HY-B0121BS | Sumatriptan-d6 succinate | Agonist | 99.63% | Unkown |
| HY-B0196B | (S)-Venlafaxine | Inhibitor | 98.0% | Unkown |
| HY-B0352A | (S)-Mirtazapine | Antagonist | 99.76% | Unkown |
| HY-B0352B | (R)-Mirtazapine | Antagonist | 99.79% | Unkown |
| HY-B0352S | Mirtazapine-d3 | Inhibitor | 99.68% | Unkown |
| HY-B0716S1 | Urapidil-d3 | 99.93% | Unkown | |
| HY-B0781S | Promethazine-d4 hydrochloride | Antagonist | 95.35% | Unkown |
| HY-B1495 | Quipazine maleate | Agonist | 98.0% | Unkown |
| HY-N0749 | Jatrorrhizine | Inhibitor | / | Unkown |
| HY-N1261 | Scutebarbatine B | 98% | Unkown | |
| HY-N1745 | 2'-O-Methylisoliquiritigenin | Activator | 99.06% | Unkown |
| HY-N2125R | Parishin C (Standard) | Agonist | 98.88% | Unkown |
| HY-N4157 | Isopteropodine | 99.13% | Unkown | |
| HY-N7514 | Strictosidinic acid | Inhibitor | 95% | Unkown |
| HY-N8934 | 6β-Hydroxytomentosin | 98.0% | Unkown | |
| HY-U00286 | 5-HT2A antagonist 1 | Antagonist | / | Unkown |
| HY-W342283 | Diminazene | / | Unkown | |
| HY-W417914 | 4-Methylamphetamine hydrochloride | Agonist | 99.86% | Unkown |
| HY-W741575 | Iloperidone carboxylic acid | Ligand | 99.6% | Unkown |
| HY-W982195 | Napamezole hydrochloride | 98.97% | Unkown | |
| HY-WAA0304 | Agmatine | / | Unkown | |
| HY-100648 | Keto Ziprasidone | Antagonist | 98.96% | Unkown |
| HY-100649 | Hydroxy ziprasidone | Antagonist | 99.53% | Unkown |
| HY-101208 | L-694247 | Agonist | 99.9% | Unkown |
| HY-101622 | 5-HT6/7 antagonist 1 | / | Unkown | |
| HY-101638 | (±)-Fabesetron hydrochloride | Antagonist | / | Unkown |
| HY-121162 | Mesembrine | Inhibitor | / | Unkown |
| HY-126057 | (R)-Praziquantel | 99.10% | Yes | |
| HY-127023 | Eicosapentaenoyl serotonin | Inhibitor | 99.0% | Unkown |
| HY-133086 | Hydrodolasetron | 98.96% | Unkown | |
| HY-138176 | 7-Hydroxyrisperidone | 98.37% | Unkown | |
| HY-156562 | 5-PT | / | Unkown | |
| HY-156775 | Antitumor agent-119 | 98.03% | Unkown | |
| HY-169127 | Seganserin | Antagonist | 99.30% | Unkown |
| HY-185345A | GR119566X dihydrochloride | Ligand | / | Unkown |
| HY-B0982S | Pindolol-d7 | Antagonist | / | Unkown |
| HY-N16471 | Escholtzine | Inhibitor | / | Unkown |
| HY-W009681 | 1-(2-Methoxyphenyl)piperazine hydrochloride | Modulator | 99.59% | Unkown |
| HY-W015169S | 5-Methoxytryptamine-d4 | Agonist | 99.7% | Unkown |
| HY-W128798 | Sulfabenz | / | Unkown | |
| HY-W779640 | 25I-NBOMe 4-methoxy isomer hydrochloride | Control | 99.3% | Unkown |
| HY-136109B | (Rac)-Ulotaront | Agonist | / | Unkown |
| HY-14336 | SB 271046 | Antagonist | / | Unkown |
| HY-145700 | UCSF648 | / | Unkown | |
| HY-15414AS | Vortioxetine-d8 hydrobromide | Inhibitor | 99.41% | Unkown |
| HY-B0031S4 | Quetiapine hemifumarate-d8 | 99.35% | Unkown | |
| HY-B0197AS | Naratriptan-d3 hydrochloride | Agonist | / | Unkown |
| HY-103107A | LY334370 hydrochloride | Agonist | / | Unkown |
| HY-105670A | PHA-543613 hydrochloride | Agonist | / | Unkown |
| HY-105670B | PHA-543613 dihydrochloride | Agonist | ≥99.0% | Unkown |
| HY-115525 | NBUMP | Ligand | / | Unkown |
| HY-162423 | CYB210010 | Agonist | / | Unkown |
| HY-14264S | Cyamemazine-d6 | Antagonist | / | Unkown |
| HY-15296S | Cabergoline-d5 | / | Unkown | |
| HY-17038S1 | Agomelatine-d4 | / | Unkown | |
| HY-17410S | Iloperidone-d3 | Antagonist | 98.8% | Unkown |
| HY-A0019S | Paliperidone-d4 | Antagonist | / | Unkown |
| HY-B0121BS1 | Sumatriptan-d6 | / | Unkown | |
| HY-B0189S1 | Mosapride-d5 | Agonist | / | Unkown |
| HY-B0457S1 | Clomipramine-d6 hydrochloride | Inhibitor | / | Unkown |
| HY-B0991S | Amoxapine-d8 | / | Unkown | |
| HY-B1110S | Nomifensine-d3 maleate | Inhibitor | / | Unkown |
| HY-W052508S | Norquetiapine-d8 | / | Unkown | |
| HY-100057 | BMY 28674 | Antagonist | / | Unkown |
| HY-100171 | PRX933 hydrochloride | Agonist | / | Unkown |
| HY-100426 | Osemozotan | Agonist | / | Unkown |
| HY-100665R | Dehydroaripiprazole (Standard) | Agonist | / | Unkown |
| HY-100703S | Pipamperone-d10 dihydrochloride | Antagonist | / | Unkown |
| HY-100851 | LY-272015 | Antagonist | / | Unkown |
| HY-100925 | Binospirone hydrochloride | / | Unkown | |
| HY-101008 | 3-MPPI | Ligand | / | Unkown |
| HY-101009 | Methiothepin maleate | Antagonist | / | Unkown |
| HY-101049 | CGS 12066 dimaleate | Agonist | / | Unkown |
| HY-101050 | Tropanserin | Antagonist | 99.92% | Unkown |
| HY-101062 | 3-AQC | Antagonist | 99.45% | Unkown |
| HY-101100A | Anpirtoline | Agonist | / | Unkown |
| HY-101105 | SB-224289 | Antagonist | / | Unkown |
| HY-101225 | 8 Hydroxy PIPAT oxalate | / | Unkown | |
| HY-101322A | MM 77 dihydrochloride | Antagonist | / | Unkown |
| HY-101324 | MK-212 | Agonist | / | Unkown |
| HY-101339 | (R)-RS 56812 | / | Unkown | |
| HY-101339A | (R)-RS 56812 hydrochloride | / | Unkown | |
| HY-101342 | RS 67506 hydrochloride | Agonist | / | Unkown |
| HY-101357 | CP 93129 | Agonist | / | Unkown |
| HY-101365 | RS-102221 | Antagonist | / | Unkown |
| HY-101367 | GR 55562 | Antagonist | / | Unkown |
| HY-101377B | S(-)-8-OH-DPAT hydrobromide | Agonist | / | Unkown |
| HY-101435 | Centpropazine | Antagonist | / | Unkown |
| HY-101480 | Xylamidine | Antagonist | / | Unkown |
| HY-101583 | NEO 376 | Modulator | 99.23% | Unkown |
| HY-101619A | Abaperidone hydrochloride | Antagonist | / | Unkown |
| HY-101630A | Deramciclane fumarate | Antagonist | / | Unkown |
| HY-101653 | MHP 133 | Inhibitor | / | Unkown |
| HY-101753 | Cianopramine | Inhibitor | / | Unkown |
| HY-102061 | Naronapride dihydrochloride | / | Unkown | |
| HY-103090A | NPS ALX Compound 4a dihydrochloride | Antagonist | / | Unkown |
| HY-103091 | Donitriptan hydrochloride | Agonist | / | Unkown |
| HY-103092 | CP-135807 | Agonist | / | Unkown |
| HY-103098 | EMDT oxalate | Agonist | / | Unkown |
| HY-103105 | LP 12 hydrochloride | Agonist | / | Unkown |
| HY-103110A | ST1936 oxalate | Agonist | / | Unkown |
| HY-103113 | MS 245 oxalate | Antagonist | 96.45% | Unkown |
| HY-103114 | AT1015 hydrochloride | Antagonist | / | Unkown |
| HY-103116 | DV-7028 hydrochloride | Antagonist | / | Unkown |
| HY-103117 | S 32212 hydrochloride | Inhibitor | / | Unkown |
| HY-103119 | LP-20 hydrochloride | / | Unkown | |
| HY-103120 | Org37684 | Antagonist | / | Unkown |
| HY-103123 | SB 258719 hydrochloride | Antagonist | / | Unkown |
| HY-103126 | DR4485 hydrochloride | Antagonist | / | Unkown |
| HY-103129A | SB-200646 | Antagonist | / | Unkown |
| HY-103130A | EMD 386088 free base | Agonist | / | Unkown |
| HY-103132 | PNU109291 | Agonist | / | Unkown |
| HY-103134 | SB 204070A | Antagonist | / | Unkown |
| HY-103139 | Altanserin hydrochloride | Ligand | / | Unkown |
| HY-103143A | SDZ 205-557 | Antagonist | / | Unkown |
| HY-103144 | WAY 629 hydrochloride | Agonist | 95.56% | Unkown |
| HY-103144A | WAY 629 | Agonist | / | Unkown |
| HY-103146 | GR125487 sulfamate | Antagonist | / | Unkown |
| HY-103148 | LY215840 | Antagonist | / | Unkown |
| HY-103151A | CP94253 | Agonist | / | Unkown |
| HY-103155 | SB-221284 | Antagonist | / | Unkown |
| HY-103199 | Carpindolol | Modulator | / | Unkown |
| HY-103212B | Azepexole | / | Unkown | |
| HY-103403 | (-)-OSU6162 hydrochloride | / | Unkown | |
| HY-103404 | PNU-96415E | Antagonist | / | Unkown |
| HY-103524R | Valerenic acid (Standard) | / | Unkown | |
| HY-10419A | AH23848 hemicalcium salt | Inhibitor | 97.0% | Unkown |
| HY-105161 | AP-521 free base | Agonist | / | Unkown |
| HY-105197A | BMS-181101 hydrochloride | Ligand | / | Unkown |
| HY-105328 | S-14489 | Antagonist | / | Unkown |
| HY-105449A | KB R6933 | Antagonist | / | Unkown |
| HY-105524 | Lirexapride | Agonist | / | Unkown |
| HY-10564S | Sarpogrelate-d3 hydrochloride | Antagonist | / | Unkown |
| HY-10564S1 | Sarpogrelate-d4 hydrochloride | Antagonist | / | Unkown |
| HY-105911 | Org 6582 | Inhibitor | / | Unkown |
| HY-105973 | Clemeprol | Inhibitor | / | Unkown |
| HY-106041A | Sercloremine hydrochloride | Inhibitor | / | Unkown |
| HY-106143 | Belaperidone | Inhibitor | / | Unkown |
| HY-106157A | Donitriptan mesylate | Agonist | / | Unkown |
| HY-106385 | PRX-03140 | Agonist | / | Unkown |
| HY-106400 | EGIS 11150 | Antagonist | / | Unkown |
| HY-106465 | Proterguride | / | Unkown | |
| HY-106484 | Tiflucarbine | Agonist | / | Unkown |
| HY-106507 | Batoprazine | Agonist | / | Unkown |
| HY-106587B | Octoclothepin dimaleate | Antagonist | / | Unkown |
| HY-106605 | Flumezapine | Antagonist | / | Unkown |
| HY-106605S | Flumezapine-d8 hydrochloride | Antagonist | / | Unkown |
| HY-106617A | Etoperidone hydrochloride | / | Unkown | |
| HY-106644A | Femoxetine hydrochloride | Inhibitor | / | Unkown |
| HY-106805 | ICI 169369 | Antagonist | / | Unkown |
| HY-106985 | R 116712 | Ligand | / | Unkown |
| HY-107018 | AR-A 2 | Antagonist | / | Unkown |
| HY-107047 | BGC-201259 | Inhibitor | / | Unkown |
| HY-107125A | AVN-322 free base | Antagonist | / | Unkown |
| HY-107664B | SR 142948 TFA | Antagonist | / | Unkown |
| HY-107847 | 2-(2-Methoxyphenoxy)ethylamine hydrochloride | 99.65% | Unkown | |
| HY-10800 | GSK-588045 | Antagonist | / | Unkown |
| HY-108106 | Y-36912 | Agonist | / | Unkown |
| HY-108139 | F-14258 | Agonist | / | Unkown |
| HY-108173 | TKS 159 | Agonist | / | Unkown |
| HY-108227 | Quetiapine sulfone | Agonist | / | Unkown |
| HY-108400 | SCH-23390 maleate | / | Unkown | |
| HY-108973 | Ifoxetine hemisulfate | Inhibitor | / | Unkown |
| HY-108973A | Ifoxetine | Inhibitor | / | Unkown |
| HY-109036A | (S)-Landipirdine | / | Unkown | |
| HY-109167A | Aramisulpride hydrochloride | Antagonist | / | Unkown |
| HY-109527 | 5-HT7 agonist 1 | Agonist | / | Unkown |
| HY-109543A | Indisetron dihydrochloride | Antagonist | / | Unkown |
| HY-110023R | Zimelidine dihydrochloride (Standard) | Inhibitor | / | Unkown |
| HY-110024A | S-14506 | Agonist | / | Unkown |
| HY-11018S1 | Risperidone-d4-1 | / | Unkown | |
| HY-110289R | (R)-Citalopram oxalate (Standard) | Inhibitor | / | Unkown |
| HY-110289S1 | (R)-Citalopram-d4 oxalate | Inhibitor | / | Unkown |
| HY-110330 | R 1485 dihydrochloride | Antagonist | / | Unkown |
| HY-110366 | WAY-181187 oxalate | Agonist | / | Unkown |
| HY-111124 | Paroxetine-d2 | / | Unkown | |
| HY-111283 | AJ-76 | Antagonist | / | Unkown |
| HY-111491 | Methiothepin | Antagonist | / | Unkown |
| HY-112390B | Syk Inhibitor II dihydrochloride dihydrate | Inhibitor | / | Unkown |
| HY-112390C | Syk Inhibitor II hydrochloride | Inhibitor | / | Unkown |
| HY-112538 | 1-(1-Naphthyl)piperazine hydrochloride | 99.22% | Unkown | |
| HY-113581 | Levemopamil | / | Unkown | |
| HY-113643 | Levemopamil hydrochloride | / | Unkown | |
| HY-113866 | E-55888 | Agonist | / | Unkown |
| HY-114459 | Mutant IDH1-IN-4 | Inhibitor | ≥99.0% | Unkown |
| HY-114540 | CP-339818 | Inhibitor | / | Unkown |
| HY-114578 | PD 118717 | Agonist | / | Unkown |
| HY-114678 | LY302148 | Agonist | / | Unkown |
| HY-115375 | R 50595 hydrochloride | / | Unkown | |
| HY-115465 | Rev1-CT/RIR PPI-IN-1 | / | Unkown | |
| HY-115724 | FPPQ | Antagonist | / | Unkown |
| HY-115774 | 5-HT4R agonist-1 | / | Unkown | |
| HY-115949 | Antitumor agent-47 | / | Unkown | |
| HY-115950 | Antitumor agent-48 | / | Unkown | |
| HY-116266 | RS 67333 | Agonist | / | Unkown |
| HY-116309 | SDZ 216-525 | Antagonist | / | Unkown |
| HY-116524 | PF-04781340 | Agonist | / | Unkown |
| HY-116908 | SB-272183 | Antagonist | / | Unkown |
| HY-116982 | BMY 7378 free base | / | Unkown | |
| HY-117046 | AVN-101 | / | Unkown | |
| HY-117063 | LEK 8841 methanesulfonate | / | Unkown | |
| HY-117090 | (rac)-AL-37350A | Agonist | / | Unkown |
| HY-117118A | AC-90179 | Agonist | / | Unkown |
| HY-117119 | VER-3323 | Agonist | / | Unkown |
| HY-117507 | U92016A hydrochloride | Agonist | 99% | Unkown |
| HY-117574 | SB 207710 | Antagonist | / | Unkown |
| HY-117575 | WAY-100135 | / | Unkown | |
| HY-117646 | FG-5893 | Agonist | / | Unkown |
| HY-117792 | LY314228 | Antagonist | / | Unkown |
| HY-117799 | LY-426965 | Antagonist | / | Unkown |
| HY-117799A | LY-426965 hydrochloride | Antagonist | / | Unkown |
| HY-118008 | Lesopitron | Agonist | / | Unkown |
| HY-118008A | Lesopitron hydrochloride | Agonist | / | Unkown |
| HY-118339 | PF-4479745 | Agonist | / | Unkown |
| HY-118450 | FR260010 free base | Antagonist | / | Unkown |
| HY-118575 | DR-4004 | Antagonist | / | Unkown |
| HY-118775 | LEK 8804 | Agonist | / | Unkown |
| HY-118835 | Zimelidine | Inhibitor | / | Unkown |
| HY-118836 | GSK215083 | Antagonist | / | Unkown |
| HY-119103 | PF-03246799 | Agonist | / | Unkown |
| HY-119103B | PF-03246799 monohydrochloride | Agonist | / | Unkown |
| HY-119775 | U92016A | / | Unkown | |
| HY-119800 | Setoperone | / | Unkown | |
| HY-119806 | TMPPAA | Agonist | / | Unkown |
| HY-119854 | Atiprosine | Antagonist | / | Unkown |
| HY-119992 | CEP-6800 | Inhibitor | / | Unkown |
| HY-120015 | BE-16627B | Inhibitor | / | Unkown |
| HY-120053 | SC-53606 | Antagonist | / | Unkown |
| HY-120239 | Ro 63-0563 | Antagonist | / | Unkown |
| HY-120339 | STK899704 | / | Unkown | |
| HY-120396 | LY 293284 | Agonist | / | Unkown |
| HY-120498 | RS-64459-193 | Agonist | / | Unkown |
| HY-120627 | BMS-442606 | Agonist | / | Unkown |
| HY-120686 | S-14671 | Agonist | / | Unkown |
| HY-120688 | L-772405 | Agonist | / | Unkown |
| HY-120820 | LY320954 | Antagonist | / | Unkown |
| HY-120939 | S14063 | Antagonist | / | Unkown |
| HY-121001 | Amanozine | Agonist | / | Unkown |
| HY-121053A | Adatanserin hydrochloride | Modulator | / | Unkown |
| HY-121085 | CID-663143 | Inhibitor | / | Unkown |
| HY-121129 | Eticlopride | Antagonist | / | Unkown |
| HY-121249 | Capeserod hydrochloride | Agonist | / | Unkown |
| HY-121299 | m-Chlorophenylbiguanide | ≥90.0% | Unkown | |
| HY-12142S | rac-Vofopitant-d3 | Antagonist | / | Unkown |
| HY-121562 | SB 714786 | Antagonist | / | Unkown |
| HY-121653B | Flesinoxan hydrochloride | Agonist | / | Unkown |
| HY-121906 | DOAM | Antagonist | / | Unkown |
| HY-122272S2 | Paroxetine-d6-1 | / | Unkown | |
| HY-122303 | 4-hydroxy DiPT hydrochloride | Agonist | / | Unkown |
| HY-122557 | AZD3676 | Ligand | / | Unkown |
| HY-122612 | SB-258585 | 99.77% | Unkown | |
| HY-123129 | RS 2232 | Inhibitor | / | Unkown |
| HY-123138 | LY206130 free base | / | Unkown | |
| HY-123206 | R-96544 free base | Antagonist | / | Unkown |
| HY-123207 | BP 554 | Agonist | / | Unkown |
| HY-123237 | KRC-108 | / | Unkown | |
| HY-123272 | E6801 | Agonist | / | Unkown |
| HY-123442 | L 775,606 | Agonist | / | Unkown |
| HY-123480 | EGIS-7625 | Inhibitor | / | Unkown |
| HY-123480A | EGIS-7625 free base | Antagonist | / | Unkown |
| HY-123567 | LY86057 | Antagonist | / | Unkown |
| HY-123695 | 5-HT4 antagonist 3 | / | Unkown | |
| HY-123704 | CGS-12066 maleate | Agonist | / | Unkown |
| HY-124007 | 4-Iodo-SAHA | Inhibitor | 99.12% | Unkown |
| HY-124086 | BHQ-O-5HT | / | Unkown | |
| HY-124117 | LY 278584 | Antagonist | / | Unkown |
| HY-124135 | SB-656104 | Antagonist | / | Unkown |
| HY-124186 | LR1143 | Inhibitor | / | Unkown |
| HY-124296 | 2C-TFM hydrochloride | Agonist | / | Unkown |
| HY-124367 | 25B-NBF hydrochloride | Agonist | / | Unkown |
| HY-124381 | ML10375 | Modulator | / | Unkown |
| HY-124412 | Paynantheine | Agonist | / | Unkown |
| HY-124908 | HT1042 | / | Unkown | |
| HY-124911 | LY53857 free base | Antagonist | / | Unkown |
| HY-124947 | PF-4522654 | Agonist | / | Unkown |
| HY-125387 | TOP1210 | / | Unkown | |
| HY-12560 | PNU-282987 free base | / | Unkown | |
| HY-125641A | AL-34662 formate | Agonist | / | Unkown |
| HY-125973 | S(-)-Cyanopindolol hemifumarate | Antagonist | / | Unkown |
| HY-12697A | NGB 2904 hydrochloride | Antagonist | / | Unkown |
| HY-129481 | LY 178210 | Inhibitor | / | Unkown |
| HY-129807 | LY-228729 | Agonist | / | Unkown |
| HY-129985 | Clovoxamine | Inhibitor | / | Unkown |
| HY-130351 | 25H-NBOMe hydrochloride | Agonist | / | Unkown |
| HY-13052 | SB-737050A | Antagonist | / | Unkown |
| HY-131284 | (S)-Dehydro Venlafaxine | / | Unkown | |
| HY-131438 | GI-149893 | Inhibitor | / | Unkown |
| HY-131531A | 5-OH-DPAT | Agonist | / | Unkown |
| HY-131954 | 5-HT3 antagonist 4 | Antagonist | / | Unkown |
| HY-13200A | BRL-15572 hydrochloride | Antagonist | / | Unkown |
| HY-13200B | BRL-15572 | Antagonist | / | Unkown |
| HY-13221A | BRL 54443 maleate | Agonist | / | Unkown |
| HY-132343S | Zolmitriptan N-Oxide-d6 | / | Unkown | |
| HY-133112 | 7-Desmethyl-3-hydroxyagomelatine | / | Unkown | |
| HY-13409B | SB 242084 monohydrochloride | Antagonist | / | Unkown |
| HY-134483 | 5-HT7/5-HT2A receptor antagonist 1 | Antagonist | / | Unkown |
| HY-135021 | 3,4-Dihydro Naratriptan | Agonist | / | Unkown |
| HY-135079 | Lerimazoline | Agonist | / | Unkown |
| HY-135131 | Synthalin hydrochloride | / | Unkown | |
| HY-135241 | 25I-NBF hydrochloride | Agonist | / | Unkown |
| HY-135392S | N-Desmethyl Pimavanserin-d9 hydrochloride | / | Unkown | |
| HY-135439 | SB-203186 | Antagonist | / | Unkown |
| HY-135456 | Ro4368554 | Antagonist | / | Unkown |
| HY-135493 | RS-56812 | Agonist | / | Unkown |
| HY-135507 | NAS-181 | Antagonist | / | Unkown |
| HY-135507A | NAS-181 free base | Antagonist | / | Unkown |
| HY-13575S | Blonanserin-d8 | Antagonist | / | Unkown |
| HY-136109H | (Rac)-Ulotaront hydrochloride | Agonist | / | Unkown |
| HY-136487 | Buspirone N-oxide | / | Unkown | |
| HY-136678 | SB 258741 | Antagonist | / | Unkown |
| HY-136678A | SB 258741 hydrochloride | Antagonist | / | Unkown |
| HY-136860 | (R)-Venlafaxine | Inhibitor | / | Unkown |
| HY-13788A | LY 344864 (S-enantiomer) | 98.0% | Unkown | |
| HY-13788B | LY 344864 hydrochloride | Agonist | / | Unkown |
| HY-138218 | ALD-52 | / | Unkown | |
| HY-138257 | (S)-Indeloxazine benzenesulfonate | Inhibitor | / | Unkown |
| HY-138906 | 25C-NBF hydrochloride | Agonist | / | Unkown |
| HY-138958 | HT1171 | Inhibitor | 99.33% | Unkown |
| HY-139062 | C6 Urea Ceramide | / | Unkown | |
| HY-139233 | 25P-NBOMe hydrochloride | Agonist | / | Unkown |
| HY-139248 | Paclitaxel octadecanedioate | / | Unkown | |
| HY-139677 | 5-HT7R antagonist 1 | Antagonist | / | Unkown |
| HY-139677A | 5-HT7R antagonist 1 free base | Antagonist | / | Unkown |
| HY-14147A | (S)-Renzapride | 98.06% | Unkown | |
| HY-14153AS | Tegaserod-13C,d3 maleate | Modulator | / | Unkown |
| HY-14153S | Tegaserod-d11 | / | Unkown | |
| HY-14154 | THRX-194556 | Agonist | / | Unkown |
| HY-14262S1 | Vilazodone-d8 hydrochloride | / | Unkown | |
| HY-143234 | mIDH1-IN-1 | Inhibitor | / | Unkown |
| HY-14325A | L-745870 trihydrochloride | Antagonist | / | Unkown |
| HY-143329 | MAO-B-IN-3 | Inhibitor | / | Unkown |
| HY-14335 | Ro 04-6790 | Antagonist | / | Unkown |
| HY-14335A | Ro 04-6790 dihydrochloride | Antagonist | / | Unkown |
| HY-14337 | MS 245 | Antagonist | / | Unkown |
| HY-14341 | E-6837 | Ligand | / | Unkown |
| HY-14349 | GSK-163090 dihydrochloride | Antagonist | / | Unkown |
| HY-143797S | Almotriptan-d6 maleate | Agonist | / | Unkown |
| HY-144272 | AChE-IN-5 | Inhibitor | / | Unkown |
| HY-14442 | ML 10302 hydrochloride | Agonist | / | Unkown |
| HY-14472S | Tesofensine-d5 | Inhibitor | / | Unkown |
| HY-14472S1 | Tesofensine-13C,d3 | Inhibitor | / | Unkown |
| HY-144764 | 5-HT1A antagonist 1 | Antagonist | / | Unkown |
| HY-14539B | Clozapine dihydrochloride | / | Unkown | |
| HY-14539S3 | Clozapine-d3 | / | Unkown | |
| HY-14541S2 | Olanzapine-d8 | 99.9% | Unkown | |
| HY-14542S | Ziprasidone-d8 | Antagonist | / | Unkown |
| HY-14544AS | Quetiapine-d4 hydrochloride | / | Unkown | |
| HY-14545B | SEP-4199 | / | Unkown | |
| HY-14557S1 | Pimavanserin-d4 | Inhibitor | / | Unkown |
| HY-14558S | Tandospirone-d8 | Agonist | / | Unkown |
| HY-145698 | UCSF678 | Agonist | / | Unkown |
| HY-145699 | UCSF686 | / | Unkown | |
| HY-145841 | 5-HT2A receptor agonist-2 | Agonist | / | Unkown |
| HY-145862 | 5-HT6/5-HT2AR antagonist-1 | Agonist | / | Unkown |
| HY-146076 | 5-HT6/5-HT2A receptor ligand-1 | Antagonist | / | Unkown |
| HY-146077 | 5-HT6/5-HT2A receptor ligand-2 | Antagonist | / | Unkown |
| HY-146201 | PDE4B/7A-IN-1 | 99.63% | Unkown | |
| HY-146202 | PDE4B/7A-IN-2 | / | Unkown | |
| HY-146232 | F 13714 | Agonist | / | Unkown |
| HY-146274 | c-Met-IN-10 | / | Unkown | |
| HY-146366 | Tubulin inhibitor 26 | Inhibitor | / | Unkown |
| HY-146505 | Tubulin polymerization-IN-6 | / | Unkown | |
| HY-146677 | 5-HT6R/MAO-B modulator 1 | / | Unkown | |
| HY-146715 | IDO/Tubulin-IN-2 | / | Unkown | |
| HY-146778 | Tubulin inhibitor 25 | Inhibitor | / | Unkown |
| HY-147399 | 5-HT7 agonist 2 | Agonist | / | Unkown |
| HY-147725 | Microtubule inhibitor 4 | Inhibitor | / | Unkown |
| HY-147727 | Microtubule inhibitor 6 | Inhibitor | / | Unkown |
| HY-147810 | 5-HT7 receptor ligand 1 | / | Unkown | |
| HY-147825 | EGFR/BRAFV600E-IN-1 | / | Unkown | |
| HY-148032 | 5-Benzyloxytryptamine | Agonist | / | Unkown |
| HY-148038 | 5-HT3 antagonist 5 | Antagonist | 99.75% | Unkown |
| HY-14835 | Burapitant | / | Unkown | |
| HY-148846 | Mosapride N-Oxide | / | Unkown | |
| HY-149247 | Antipsychotic agent-2 | / | Unkown | |
| HY-149359 | IHMT-IDH1-053 | Inhibitor | / | Unkown |
| HY-149510 | MET/PDGFRA-IN-1 | / | Unkown | |
| HY-149511 | MET/PDGFRA-IN-2 | / | Unkown | |
| HY-149523 | Anticancer agent 157 | / | Unkown | |
| HY-149952 | ATR-IN-23 | Inhibitor | / | Unkown |
| HY-150593 | IRAK4-IN-16 | Inhibitor | / | Unkown |
| HY-150594 | IRAK4-IN-17 | Inhibitor | / | Unkown |
| HY-151541 | MLKL-IN-3 | Inhibitor | / | Unkown |
| HY-15296A | Cabergoline diphosphate | / | Unkown | |
| HY-15296S1 | Cabergoline-d6 | / | Unkown | |
| HY-15394S | (Rac)-Rotigotine-d7 (hydrochloride) | / | Unkown | |
| HY-15414S | Vortioxetine-d8 | Inhibitor | / | Unkown |
| HY-15414S3 | Vortioxetine-d3 | / | Unkown | |
| HY-155116 | 5-HT6 agonist 1 | Agonist | / | Unkown |
| HY-155117 | MRS7925 | Antagonist | / | Unkown |
| HY-155152 | P-gp/BCRP-IN-2 | Inhibitor | / | Unkown |
| HY-155203 | Anticancer agent 154 | Inducer | / | Unkown |
| HY-155206 | (+)-OSU6162 | Agonist | 98.27% | Unkown |
| HY-155215 | Tenilapine | Antagonist | / | Unkown |
| HY-155240 | Tyrosinase-IN-13 | Inhibitor | / | Unkown |
| HY-155316 | 5-HT6R antagonist 2 | Antagonist | / | Unkown |
| HY-155330 | PZ-1922 | / | Unkown | |
| HY-155330A | PZ-1922 free base | / | Unkown | |
| HY-155780 | Anti-inflammatory agent 52 | Inhibitor | / | Unkown |
| HY-155781 | Anti-inflammatory agent 53 | Inhibitor | / | Unkown |
| HY-156017 | 5-HT6R antagonist 1 | Antagonist | / | Unkown |
| HY-156098 | c-Met-IN-19 | Inhibitor | / | Unkown |
| HY-156532A | 5-HT2C agonist-3 free base | Agonist | / | Unkown |
| HY-156533 | 5-HT2 agonist-1 | Agonist | / | Unkown |
| HY-156533A | 5-HT2 agonist-1 free base | Agonist | / | Unkown |
| HY-156534 | 5-HT2A&5-HT2C agonist-1 | Agonist | / | Unkown |
| HY-156792 | RIOK2-IN-1 | Inhibitor | / | Unkown |
| HY-156807 | LY 367265 | / | Unkown | |
| HY-156878 | Antiproliferative agent-39 | / | Unkown | |
| HY-156879 | Antiproliferative agent-40 | / | Unkown | |
| HY-157085 | BX-2819 | Inhibitor | / | Unkown |
| HY-157425 | 5-HT2CR agonist 1 | Agonist | / | Unkown |
| HY-157429 | 25N-N1-Nap | Agonist | / | Unkown |
| HY-157563 | Dopamine D4 receptor ligand 2 | / | Unkown | |
| HY-157963 | RIPK1-IN-23 | Inhibitor | / | Unkown |
| HY-158627 | JPC0323 Oleate | Modulator | / | Unkown |
| HY-159492 | 5-HT7 receptor ligand 2 | / | Unkown | |
| HY-159567 | Ferroptosis-IN-11 | Inhibitor | / | Unkown |
| HY-159771 | FAP6-19 | Ligand | / | Unkown |
| HY-159942 | 5-HT7R antagonist 3 | / | Unkown | |
| HY-160170 | Necrosis inhibitor 3 | Inhibitor | / | Unkown |
| HY-160656 | 5-HT/NA Reuptake inhibitor-1 | / | Unkown | |
| HY-161105 | FPIP | / | Unkown | |
| HY-161282 | hCAII-IN-10 | Inhibitor | / | Unkown |
| HY-161327 | HBV-IN-44 | Inhibitor | / | Unkown |
| HY-161361 | MLKL-IN-7 | Inhibitor | / | Unkown |
| HY-161614 | Tubulin inhibitor 44 | Inhibitor | / | Unkown |
| HY-161628 | Tapcin | Inhibitor | / | Unkown |
| HY-161664 | ZINC866533340 | / | Unkown | |
| HY-161852 | PI3K-IN-55 | / | Unkown | |
| HY-161863 | Tubulin polymerization-IN-67 | / | Unkown | |
| HY-161900 | Apoptosis inducer 22 | / | Unkown | |
| HY-161930 | PROTAC GPX4 degrader-3 | Inducer | / | Unkown |
| HY-161948 | Ferroptosis inducer-4 | Inducer | / | Unkown |
| HY-161972 | ZX782 | / | Unkown | |
| HY-162083 | CB2R/5-HT1AR agonist 1 | Agonist | / | Unkown |
| HY-162176 | 5-HT2A agonist 2 | Agonist | / | Unkown |
| HY-162511 | IP2015 | Inhibitor | / | Unkown |
| HY-162585 | 5-HT1AR agonist 1 | Agonist | / | Unkown |
| HY-162591 | MR33317 | / | Unkown | |
| HY-162636 | 5HT6-ligand-2 | Antagonist | / | Unkown |
| HY-162682 | 5-HT6R antagonist 4 | Antagonist | / | Unkown |
| HY-162716 | GPX4-IN-10 | Inducer | / | Unkown |
| HY-162718 | GPX4-IN-12 | Inducer | / | Unkown |
| HY-162721 | Anticancer agent 242 | / | Unkown | |
| HY-162927 | p53-MDM2-IN-6 | / | Unkown | |
| HY-163150 | 5-HT6R antagonist 3 | Antagonist | / | Unkown |
| HY-163205 | VU6067416 | Agonist | / | Unkown |
| HY-163280 | JGB-1-155 | Activator | / | Unkown |
| HY-163322 | MAO-A inhibitor 2 | Inhibitor | / | Unkown |
| HY-163345 | 5-HT7R antagonist 2 | Antagonist | / | Unkown |
| HY-163390 | RIP1 kinase inhibitor 9 | Inhibitor | / | Unkown |
| HY-163456 | Chx-HT | Inducer | / | Unkown |
| HY-163692 | Tubulin polymerization-IN-64 | / | Unkown | |
| HY-163728 | DSP-6745 | Modulator | / | Unkown |
| HY-163806 | NT376 | Inhibitor | / | Unkown |
| HY-164083 | GR65630 | Antagonist | / | Unkown |
| HY-165044 | 1,3-Di-α-linolenoyl glycerol | / | Unkown | |
| HY-165357 | (+)-Alprenolol | / | Unkown | |
| HY-165440 | Cyclobenzaprine | / | Unkown | |
| HY-165527 | S18327 | Antagonist | / | Unkown |
| HY-165594A | AT-1015 | Antagonist | / | Unkown |
| HY-165624 | LY-41 | / | Unkown | |
| HY-165624A | (S)-LY-41 | Agonist | / | Unkown |
| HY-165624B | (R)-LY-41 | Agonist | / | Unkown |
| HY-16567S | Asenapine-13C,d3 hydrochloride | Antagonist | / | Unkown |
| HY-167238 | RS-30199 | Modulator | / | Unkown |
| HY-16728A | Rapastinel acetate | / | Unkown | |
| HY-167639 | (S)-Ramosetron | Antagonist | / | Unkown |
| HY-167648 | PD 158771 | Agonist | / | Unkown |
| HY-167663A | (S)-Ebalzotan | Agonist | / | Unkown |
| HY-167675 | R-137696 | Agonist | / | Unkown |
| HY-167677 | ASP-2205 | Agonist | / | Unkown |
| HY-167893 | AGH-107 | Agonist | / | Unkown |
| HY-168021 | MAO-A/SERT-IN-1 | Inhibitor | / | Unkown |
| HY-168096 | iNOs-IN-5 | Inhibitor | / | Unkown |
| HY-168241 | Flucopride | / | Unkown | |
| HY-168333 | 5-HT6 inverse agonist 1 | / | Unkown | |
| HY-168334 | 5-HT2C agonist-4 | Agonist | / | Unkown |
| HY-169001 | 5-HT2A/5-HT2C inverse agonist 1 | Agonist | / | Unkown |
| HY-169074 | Thalidomide-N-methylpiperazine | / | Unkown | |
| HY-169133 | GDCNF-11 | / | Unkown | |
| HY-169156 | HDAC6-IN-49 | Inhibitor | / | Unkown |
| HY-169382 | Melatonin-Tamoxifen Conjugate | Inhibitor | / | Unkown |
| HY-169394 | 5-HT1AR agonist 2 | / | Unkown | |
| HY-169409 | VEGFR-2-IN-59 | Inhibitor | / | Unkown |
| HY-169446 | ALEPH hydrochloride | Agonist | / | Unkown |
| HY-169451 | Cannabidiolic acid methyl ester | Modulator | / | Unkown |
| HY-169467 | 5-Chloro-α-methyltryptamine | Agonist | / | Unkown |
| HY-169611 | Serotonin maleate | / | Unkown | |
| HY-169786 | 5-HT2A receptor agonist-5 | Agonist | / | Unkown |
| HY-169791 | ECPLA | Agonist | / | Unkown |
| HY-169825 | (S)-PF-04995274 | Agonist | / | Unkown |
| HY-170053 | 4-Hydroxy MPT | Agonist | / | Unkown |
| HY-17032A | Indeloxazine hydrochloride | Inhibitor | / | Unkown |
| HY-170387 | MRS8209 | Antagonist | / | Unkown |
| HY-170475 | 5-MeO-MET | Agonist | / | Unkown |
| HY-170834 | Antiproliferative agent-66 | Inhibitor | / | Unkown |
| HY-170908 | Pellotine | Antagonist | / | Unkown |
| HY-170932 | EGFR/COX-2-IN-1 | / | Unkown | |
| HY-170959 | NYY-6a | Inhibitor | / | Unkown |
| HY-170966 | HDAC1-IN-9 | Inhibitor | / | Unkown |
| HY-170982 | MS910 | Degrader | / | Unkown |
| HY-171052 | 5-HT6R antagonist 5 | Antagonist | / | Unkown |
| HY-171194 | VU0530244 | Antagonist | / | Unkown |
| HY-171195 | VU0631019 | Antagonist | / | Unkown |
| HY-171232 | Jimscaline | Agonist | / | Unkown |
| HY-171235 | 5-HT2A antagonist 3 | Antagonist | / | Unkown |
| HY-171745 | ATR-IN-32 | Inhibitor | / | Unkown |
| HY-171790 | W-2451 | Antagonist | / | Unkown |
| HY-171794 | AZD1134 | Antagonist | / | Unkown |
| HY-171906A | 1-Arachidonoyl-2-hydroxy-sn-glycero-3-PA sodium | Inhibitor | / | Unkown |
| HY-172258 | 5-HT2B antagonist-2 | Inhibitor | / | Unkown |
| HY-172339 | 4-AcO-DALT hydrochloride | Inhibitor | / | Unkown |
| HY-172425 | Deulumateperone | / | Unkown | |
| HY-172617 | APD-94 | / | Unkown | |
| HY-172678 | PUC-10 | / | Unkown | |
| HY-172679 | PUC-55 | Inhibitor | / | Unkown |
| HY-172763 | EDMA hydrochloride | / | Unkown | |
| HY-172924 | NLX-266 | Agonist | / | Unkown |
| HY-172978 | 5-HT2A receptor agonist-8 | Agonist | / | Unkown |
| HY-172980 | 5-HT2A receptor agonist-9 | Agonist | / | Unkown |
| HY-172981 | CTW0404 | Modulator | / | Unkown |
| HY-172982 | CTW0419 | Modulator | / | Unkown |
| HY-172995 | RS130-180 | Agonist | / | Unkown |
| HY-173043 | 5-HT6R antagonist 6 | Antagonist | / | Unkown |
| HY-173044 | 5-HT1AR/5-HT6R ligand-1 | / | Unkown | |
| HY-173045 | 5-HT5AR/5-HT6R ligand-1 | Ligand | / | Unkown |
| HY-173074 | Microtubulin-IN-1 | / | Unkown | |
| HY-173124 | CDK2/FLT4/PDGFRA-IN-1 | / | Unkown | |
| HY-173131 | 5-HT4R agonist-2 | Agonist | / | Unkown |
| HY-173166 | PPARγ agonist 17 | Agonist | / | Unkown |
| HY-173227 | TrkC-IN-1 | Inhibitor | / | Unkown |
| HY-173269 | 5-HT2A receptor agonist-7 | Modulator | / | Unkown |
| HY-173445 | RIPK1-IN-30 | Inhibitor | / | Unkown |
| HY-173451 | TAAR1/5-H-2CR agonist-1 | Agonist | / | Unkown |
| HY-17382S | Metoclopramide-d3 | Antagonist | / | Unkown |
| HY-17385S1 | Atomoxetine-d7 hydrochloride | / | Unkown | |
| HY-17410S1 | Iloperidone-d3 hydrochloride | Antagonist | / | Unkown |
| HY-174146 | 5-HT1A agonist 1 | Agonist | / | Unkown |
| HY-174306 | MARY1 | / | Unkown | |
| HY-174448 | WEE1-IN-12 | Inhibitor | / | Unkown |
| HY-174466 | 5-HT2AR ligand 1 | / | Unkown | |
| HY-174898 | 5-HT2C agonist-9 | Agonist | / | Unkown |
| HY-174909 | 5-HT2A receptor agonist-11 | Agonist | / | Unkown |
| HY-175041 | GPX4-IN-18 | 95.79% | Unkown | |
| HY-175191 | 5-HT2A agonist 4 | Agonist | / | Unkown |
| HY-175192 | 5-HT2A agonist 5 | Agonist | / | Unkown |
| HY-175194 | 5-HT2C agonist-6 | Agonist | / | Unkown |
| HY-175205 | TGF-β2-IN-1 | Inhibitor | / | Unkown |
| HY-175263 | Aminochalcone 4AAF | Inhibitor | / | Unkown |
| HY-175285 | 5-HT2AR-IN-1 | Inhibitor | / | Unkown |
| HY-175509 | 5-HT2A agonist 6 | Agonist | / | Unkown |
| HY-175511 | 5-HT2A agonist 7 | Agonist | / | Unkown |
| HY-175514 | 5-HT2C agonist-10 | Activator | / | Unkown |
| HY-175515 | 5-HT2C agonist-11 | Agonist | / | Unkown |
| HY-175532 | M4 mAChR Modulator-2 | Activator | / | Unkown |
| HY-175649 | LATS1/2-IN-1 | Inhibitor | / | Unkown |
| HY-175657 | 5-HT2A receptor agonist-12 | Agonist | / | Unkown |
| HY-175675 | P2Y1 antagonist 4 | / | Unkown | |
| HY-175816 | 5-HT6R/FAAH modulator 1 | / | Unkown | |
| HY-175822 | 5-HT2A inverse agonist-1 | Inhibitor | / | Unkown |
| HY-175852 | Ferroptosis inducer-11 | / | Unkown | |
| HY-176060 | Platelet aggregation-IN-3 | Ligand | / | Unkown |
| HY-176146 | Keap1/Nrf2/ARE activator 1 | Activator | / | Unkown |
| HY-176216 | 5-HT2C agonist-5 | Agonist | / | Unkown |
| HY-176279 | Hsp90-IN-42 | Inhibitor | / | Unkown |
| HY-176436S | GW-117 | / | Unkown | |
| HY-176717 | 5-HT1AR agonist 3 | Agonist | / | Unkown |
| HY-176721 | 5-HT2A receptor agonist-10 | Agonist | / | Unkown |
| HY-176869 | EMC-AANL-DOX | / | Unkown | |
| HY-176910 | IHCH-7179 | Modulator | / | Unkown |
| HY-177101 | Luvesilocin | Agonist | / | Unkown |
| HY-177224 | Antitumor agent-205 | / | Unkown | |
| HY-177314 | 5-HT1A antagonist 2 | Antagonist | / | Unkown |
| HY-177914 | MEK-IN-7 | Inhibitor | / | Unkown |
| HY-178323 | MW073 | / | Unkown | |
| HY-178352 | MAO-B-IN-49 | / | Unkown | |
| HY-178370 | Ferroptosis inducer-12 | Inducer | 96.32% | Unkown |
| HY-178417 | Angustilongine M | / | Unkown | |
| HY-178511 | KIF18A-IN-17 | Inhibitor | / | Unkown |
| HY-178760 | TGF-8027 | Agonist | / | Unkown |
| HY-178960 | Tubulin-IN-59 | / | Unkown | |
| HY-178998 | 5-HT7R antagonist 5 | Antagonist | / | Unkown |
| HY-179008 | 5-HT2CR agonist 2 | Agonist | / | Unkown |
| HY-179008A | (S)-5-HT2CR agonist 1 | Agonist | / | Unkown |
| HY-179021 | COX-2/15-LOX-IN-7 | Inhibitor | / | Unkown |
| HY-179063 | 5-HT2A receptor agonist-13 | / | Unkown | |
| HY-179140 | EGFR/VEGFR2-IN-8 | Inhibitor | / | Unkown |
| HY-179291 | 5-HT2A agonist 8 | Agonist | / | Unkown |
| HY-179464 | CC-M-1 | Inhibitor | / | Unkown |
| HY-179684 | PCC0105005 | / | Unkown | |
| HY-179706 | VS3 | Inhibitor | / | Unkown |
| HY-179713 | D2R/D3R/5-HT1AR agonist 1 | Agonist | / | Unkown |
| HY-179724 | PZ-1657 | Inhibitor | / | Unkown |
| HY-179724A | PZ-1657 hydrochloride | Inhibitor | / | Unkown |
| HY-179725 | PZ-1129 | Ligand | / | Unkown |
| HY-180185 | 5-HT2A&5-HT2C agonist-2 | Agonist | / | Unkown |
| HY-180197 | PICK1 PDZ-IN-1 | Inhibitor | / | Unkown |
| HY-180244 | P2L-003 | / | Unkown | |
| HY-180327 | NEPP11 | / | Unkown | |
| HY-180372 | CSP-2503 | Agonist | / | Unkown |
| HY-180379 | Pelanserin | / | Unkown | |
| HY-180449 | AXIN2/β-catenin-IN-1 | Inhibitor | / | Unkown |
| HY-180465 | 5-HT2C agonist-12 | Agonist | / | Unkown |
| HY-180466 | 5-HT2C antagonist 1 | Antagonist | / | Unkown |
| HY-180584 | 5-HT2A agonist 9 | Inhibitor | / | Unkown |
| HY-180617 | 5-HT2CR allosteric modulator 1 | Agonist | / | Unkown |
| HY-180806 | RIPK1-IN-39 | Inhibitor | / | Unkown |
| HY-181351 | PSN09 | Agonist | / | Unkown |
| HY-181575 | TPH2 agonist-1 | Inhibitor | / | Unkown |
| HY-181598 | GPX4 degrader-1 | / | Unkown | |
| HY-181613 | 5-HT2A&5-HT2C agonist-3 | Agonist | / | Unkown |
| HY-181878 | Z8779877149 | Ligand | / | Unkown |
| HY-181977 | RPI-GLYT2-82 | Inhibitor | / | Unkown |
| HY-181984 | AGH-194 | Agonist | / | Unkown |
| HY-182091 | CYD-1-79 | / | Unkown | |
| HY-182244 | SERT/NET-IN-1 | Antagonist | / | Unkown |
| HY-182285 | 5-HT7 modulator-1 | / | Unkown | |
| HY-182285A | 5-HT7 modulator-1 hydrochloride | / | Unkown | |
| HY-182373 | 5-HT2C agonist-13 | Agonist | / | Unkown |
| HY-182389 | NLX-219 | Agonist | / | Unkown |
| HY-182440 | AZD3783 | Antagonist | / | Unkown |
| HY-182472 | AL-38022A | Agonist | / | Unkown |
| HY-182504 | NRA-0562 | / | Unkown | |
| HY-182584 | S 15931 | Inhibitor | / | Unkown |
| HY-182597 | Tracizoline | / | Unkown | |
| HY-182677 | EF-7412 | Antagonist | / | Unkown |
| HY-182695 | AS2030680 | Antagonist | / | Unkown |
| HY-182701 | 5-HT3 antagonist-7 | Antagonist | / | Unkown |
| HY-182706 | NSC 373981 | Inhibitor | / | Unkown |
| HY-18276 | SUVN-507 | Antagonist | / | Unkown |
| HY-183136 | Batanopride | Antagonist | / | Unkown |
| HY-183357 | GABAAR/5-HT2AR modulator-1 | / | Unkown | |
| HY-183577 | 5-HT2A agonist 10 | Agonist | / | Unkown |
| HY-183652 | 5-HT2C-agonist-14 | Inhibitor | / | Unkown |
| HY-183734 | Obuprazine | / | Unkown | |
| HY-183805 | 5-HT6R/FAAH modulator 2 | / | Unkown | |
| HY-183908 | GSK-3β-IN-29 | Inhibitor | / | Unkown |
| HY-184666 | Fluprofylline | Antagonist | / | Unkown |
| HY-185056 | Ferfluor-1 | Inhibitor | 99.33% | Unkown |
| HY-18596 | SB-215505 | Antagonist | 98.91% | Unkown |
| HY-186169 | R-MDDMA | Modulator | / | Unkown |
| HY-186170 | R-MDMA | Antagonist | / | Unkown |
| HY-186170B | (R,S)-MDMA | Agonist | / | Unkown |
| HY-19029 | SDZ 208-912 | / | Unkown | |
| HY-19158A | Org-13011 fumarate | Agonist | / | Unkown |
| HY-19225A | Ensaculin free base | / | Unkown | |
| HY-19238 | BMS-181885 | Agonist | / | Unkown |
| HY-19358A | 2-Methyl-5-HT hydrochloride | Agonist | / | Unkown |
| HY-19358B | 2-Methyl-5-HT maleate | Agonist | / | Unkown |
| HY-19417 | Wf-516 hydrochloride | / | Unkown | |
| HY-19578A | Isamoltan hydrochloride | / | Unkown | |
| HY-19578B | Isamoltane hemifumarate | Antagonist | / | Unkown |
| HY-19668 | SGS-518 | Antagonist | / | Unkown |
| HY-19668A | SGS518 oxalate | Antagonist | / | Unkown |
| HY-19682A | Enciprazine dihydrochloride | / | Unkown | |
| HY-19686A | Ipsapirone hydrochloride | Modulator | / | Unkown |
| HY-19733S | Lumateperone-13C,d3 tosylate | / | Unkown | |
| HY-19733S1 | Lumateperone-d4 tosylate | / | Unkown | |
| HY-19818 | NAN-190 | / | Unkown | |
| HY-19863A | F-15599 tosylate | Agonist | / | Unkown |
| HY-21994 | Org-12962 hydrochloride | Agonist | / | Unkown |
| HY-21995 | BGC20-761 | Antagonist | / | Unkown |
| HY-44132 | Dehydro Palonosetron | Antagonist | / | Unkown |
| HY-46286 | TTFB | Control | 99.83% | Unkown |
| HY-59201 | A-582941 | / | Unkown | |
| HY-70050AS | Alosetron-d3 | Antagonist | / | Unkown |
| HY-A0007S | Rotigotine-d7 hydrochloride | Agonist | / | Unkown |
| HY-A0019AS | Paliperidone palmitate-d4 | / | Unkown | |
| HY-A0021S | Palonosetron-d3 hydrochloride | / | Unkown | |
| HY-A0039S1 | Eletriptan-d5 | / | Unkown | |
| HY-A0039S2 | Eletriptan-d5 hydrochloride | / | Unkown | |
| HY-A0077AS | Perphenazine-d8 dihydrochloride | Inhibitor | ≥98.0% | Unkown |
| HY-A0077S2 | Perphenazine-d6 fumarate | / | Unkown | |
| HY-A0095B | Flibanserin hydrochloride | / | Unkown | |
| HY-A0095S | Flibanserin-d4 | Modulator | / | Unkown |
| HY-A0095S1 | Flibanserin-d4-1 | Modulator | 99.28% | Unkown |
| HY-A0157 | Dimethothiazine | Antagonist | / | Unkown |
| HY-A0157A | Dimethothiazine mesylate | Antagonist | / | Unkown |
| HY-A0171A | Benzoctamine hydrochloride | Inhibitor | / | Unkown |
| HY-A0172 | Captodiame | / | Unkown | |
| HY-A0175 | Butriptyline | Inhibitor | / | Unkown |
| HY-A0175A | Butriptyline hydrochloride | Inhibitor | / | Unkown |
| HY-A0274 | Ramosetron | Antagonist | / | Unkown |
| HY-B0002BS1 | Ondansetron-d3 | / | Unkown | |
| HY-B0002BS2 | Ondansetron-13C,d3 | Antagonist | / | Unkown |
| HY-B0002S1 | Ondansetron-d6 hydrochloride | / | Unkown | |
| HY-B0031S3 | Quetiapine-d8 hemifumarate | / | Unkown | |
| HY-B0031S5 | Quetiapine-d4-1 fumarate | / | Unkown | |
| HY-B0032AS | Lurasidone-d8 | / | Unkown | |
| HY-B0032S | Lurasidone-d8 hydrochloride | Antagonist | / | Unkown |
| HY-B0115S | Pizotyline-d3 | Antagonist | / | Unkown |
| HY-B0121BS2 | Sumatriptan-d5 | Agonist | / | Unkown |
| HY-B0121BS3 | Sumatriptan-d6 formate | Agonist | / | Unkown |
| HY-B0196S1 | Venlafaxine-d6-1 | Inhibitor | 99.9% | Unkown |
| HY-B0196S4 | Venlafaxine-d9 | / | Unkown | |
| HY-B0206S | Rizatriptan-d6 benzoate | Agonist | / | Unkown |
| HY-B0229S | Zolmitriptan-d6 | Agonist | / | Unkown |
| HY-B0352AS | (S)-Mirtazapine-d3 | Antagonist | 99.0% | Unkown |
| HY-B0352BS | (R)-Mirtazapine-d3 | Antagonist | / | Unkown |
| HY-B0352S2 | Mirtazapine-d4 | Antagonist | / | Unkown |
| HY-B0352S3 | Mirtazapine-d4 hydrochloride | Antagonist | / | Unkown |
| HY-B0383AS | Almotriptan hydrochloride-d6 | Agonist | 97.30% | Unkown |
| HY-B0383AS2 | Almotriptan-d3 benzoate | Agonist | / | Unkown |
| HY-B0457S2 | Clomipramine-13C,d3 hydrochloride | Inhibitor | / | Unkown |
| HY-B0602S2 | Desvenlafaxine-d6 | Inhibitor | 98.89% | Unkown |
| HY-B0602S3 | Desvenlafaxine-d10 | Inhibitor | / | Unkown |
| HY-B0716S2 | Urapidil-d4 | / | Unkown | |
| HY-B0731AS | Perospirone-d8 | / | Unkown | |
| HY-B0740S3 | Cyclobenzaprine-d3-1 hydrochloride | / | Unkown | |
| HY-B0750S | Dolasetron-d4 | Antagonist | / | Unkown |
| HY-B0750S1 | Dolasetron-d5 | Antagonist | / | Unkown |
| HY-B0781S1 | Promethazine-d3 hydrochloride | Antagonist | / | Unkown |
| HY-B1115S1 | Buspirone-d8 (di(hydrochloride)) | / | Unkown | |
| HY-B1396S | Nefazodone-d6 hydrochloride | Antagonist | / | Unkown |
| HY-B1396S1 | Nefazodone-d6 dihydrochloride | Antagonist | / | Unkown |
| HY-B1473S2 | Serotonin-13C,D4 | / | Unkown | |
| HY-B1517B | Alprenolol benzoate | Antagonist | / | Unkown |
| HY-B1562C | Bopindolol fumarate | / | Unkown | |
| HY-B1658BS | Frovatriptan-d3 succinate | Agonist | / | Unkown |
| HY-B1658S | Frovatriptan-d3 hydrochloride | / | Unkown | |
| HY-B1714A | NSC 601980 | 98.11% | Unkown | |
| HY-B1942 | Diphenyl sulfone | Antagonist | 99.97% | Unkown |
| HY-G0014S | Quetiapine Sulfoxide-d8 | / | Unkown | |
| HY-N0049R | Nuciferine (Standard) | / | Unkown | |
| HY-N0998 | 1,7-Bis(4-hydroxyphenyl)-hepta-4E,6E-dien-3-one | Inhibitor | / | Unkown |
| HY-N10158 | 1,7-Bis(4-hydroxyphenyl)-3-hydroxy-1,3-heptadien-5-one | / | Unkown | |
| HY-N12437 | Marsdenoside B | / | Unkown | |
| HY-N1631 | 1-Hydroxyrutecarpine | / | Unkown | |
| HY-N1632 | 1-Isomangostin hydrate | / | Unkown | |
| HY-N16471A | Escholtzine perchlorate | Inhibitor | 99.0% | Unkown |
| HY-N1655 | 2,3-Dihydroamentoflavone 7,4'-dimethyl ether | Inhibitor | / | Unkown |
| HY-N17610 | 2',4'-Dihydroxydihydrochalcone | / | Unkown | |
| HY-N18471 | 5,7-Dihydroxytryptamine | Ligand | / | Unkown |
| HY-N18471A | 5,7-Dihydroxytryptamine hydrobromide | Ligand | / | Unkown |
| HY-N18471B | 5,7-Dihydroxytryptamine creatinine sulfate | Ligand | / | Unkown |
| HY-N4156 | Pteropodine | 99.59% | Unkown | |
| HY-N6771S | Cyclopiazonic acid-13C20 | / | Unkown | |
| HY-N7175 | 5,8-Epidioxyergosta-6,9(11),22-trien-3-ol | Inducer | / | Unkown |
| HY-N8025 | Nephthenol | / | Unkown | |
| HY-N8387 | Neogrifolin | Inhibitor | / | Unkown |
| HY-N8412 | 4-O-Methylbutein | / | Unkown | |
| HY-N8462 | 6-O-Nicotinoylscutebarbatine G | / | Unkown | |
| HY-N8464 | Juncuenin D | Inhibitor | / | Unkown |
| HY-N8491 | Dihydrocarveol | / | Unkown | |
| HY-N9596S | Stigmasta-4,22-dien-3-one-d5 | / | Unkown | |
| HY-P10994 | Eps8 peptide 327 | / | Unkown | |
| HY-P10995 | TAT-327 | / | Unkown | |
| HY-P1134 | Galanin (1-15) (porcine, rat) | Modulator | / | Unkown |
| HY-P1303A | CART(62-76)(human,rat) TFA | Inhibitor | / | Unkown |
| HY-P1435A | NoxA1ds TFA | Inhibitor | / | Unkown |
| HY-P2624 | st-Ht31 | Inhibitor | / | Unkown |
| HY-P3116 | Thiocoraline | Inhibitor | / | Unkown |
| HY-P3641 | Kisspeptin 13 | Activator | / | Unkown |
| HY-P3839 | Nocistatin | Agonist | / | Unkown |
| HY-U00121A | Lintopride hydrochloride | Antagonist | / | Unkown |
| HY-W011040 | LY320135 | / | Unkown | |
| HY-W018475B | Rizatriptan hemisulfate hemihydrate | Agonist | / | Unkown |
| HY-W061043 | DOV-216,303 | Inhibitor | / | Unkown |
| HY-W073336A | 1-(3-Fluorophenyl)piperazine hydrochloride | Antagonist | 98.03% | Unkown |
| HY-W1123900 | 5-HT2A agonist 3 | Agonist | / | Unkown |
| HY-W130288 | 1-(1-Naphthyl)piperazine | / | Unkown | |
| HY-W284026 | PIM-35 | Inhibitor | / | Unkown |
| HY-W296398 | 5-Bromo-N,N-dimethyltryptamine | Inhibitor | / | Unkown |
| HY-W335976 | Almotriptan hydrochloride | Agonist | / | Unkown |
| HY-W609889 | 5-HT2A receptor agonist-14 | Agonist | / | Unkown |
| HY-W615853 | 5-HT1A modulator 4 | Ligand | / | Unkown |
| HY-W653969 | Arotinolol-d5 hydrochloride | Antagonist | / | Unkown |
| HY-W654010 | Lurasidone-d8-1 hydrochloride | / | Unkown | |
| HY-W681014 | 5-Fluoro-α-methyltryptamine hydrochloride | Activator | / | Unkown |
| HY-W682464 | 4-MeO-MiPT | / | Unkown | |
| HY-W700149 | N,O-Didesmethylvenlafaxine-d3 | / | Unkown | |
| HY-W707158 | Norfenfluramine hydrochloride | / | Unkown | |
| HY-W714110 | UH 301 hydrochloride | Antagonist | / | Unkown |
| HY-W716520 | Cariprazine-d8-1 | / | Unkown | |
| HY-W719093 | Citalopram hydrochloride | Inhibitor | / | Unkown |
| HY-W727999 | Koenimbine | Inducer | / | Unkown |
| HY-W742404 | Bopindolol-d9 | / | Unkown | |
| HY-W742532 | ETH-LAD | / | Unkown | |
| HY-W743888 | AL-LAD | / | Unkown | |
| HY-W744038 | Zotepine-d6 | / | Unkown | |
| HY-W744750 | TDHL-d10 | / | Unkown | |
| HY-W745430 | Cyproheptadine hydrochloride-d3 | / | Unkown | |
| HY-W746031 | WAY-181187 hydrochloride | Agonist | / | Unkown |
| HY-W748758 | (Z)-Thiothixene-d8 | / | Unkown | |
| HY-W751350 | Cyclobenzaprine-d6 | / | Unkown | |
| HY-W769256 | Scopolamine-13C,d3 hydrobromide | / | Unkown | |
| HY-W777120 | Cisapride-13C,d3 | / | Unkown | |
| HY-W777526 | Nitisinone-13C6 | / | Unkown | |
| HY-W777959 | Azasetron Hydrochloride-13C,d3 | / | Unkown | |
| HY-W794785 | WAY 208466 | Agonist | / | Unkown |
| HY-W822786 | GR125487 | Antagonist | / | Unkown |
| HY-W903631 | SB-216641 | Antagonist | / | Unkown |
| HY-Z4690 | Zolmitriptan N-Oxide | / | Unkown | |
| HY-100926 | MDL 72832 hydrochloride | / | Unkown | |
| HY-101324AR | MK-212 monohydrochloride (Standard) | Agonist | / | Unkown |
| HY-101344 | Cyanopindolol fumarate | Antagonist | / | Unkown |
| HY-101632 | Irindalone | Antagonist | / | Unkown |
| HY-101638A | (±)-Fabesetron | Antagonist | / | Unkown |
| HY-101641 | NRA-0160 | Antagonist | / | Unkown |
| HY-101668 | Sulamserod | Antagonist | / | Unkown |
| HY-101668A | Sulamserod hydrochloride | Antagonist | / | Unkown |
| HY-101727 | Nexopamil racemate | / | Unkown | |
| HY-103143 | SDZ 205-557 hydrochloride | Antagonist | / | Unkown |
| HY-103151R | CP94253 hydrochloride (Standard) | Agonist | / | Unkown |
| HY-103212 | Azepexole dihydrochloride | Agonist | / | Unkown |
| HY-105108 | Cilansetron hydrochloride hydrate | Antagonist | / | Unkown |
| HY-105109B | (S)-Cilansetron | Control | / | Unkown |
| HY-105127 | Brofaromine hydrochloride | Inhibitor | / | Unkown |
| HY-105201A | Fabesetron hydrochloride | Antagonist | / | Unkown |
| HY-105479 | KF 18259 | Antagonist | / | Unkown |
| HY-106124 | IS-159 | Agonist | / | Unkown |
| HY-106644 | Femoxetine | Inhibitor | / | Unkown |
| HY-106807 | Litoxetine | Inhibitor | / | Unkown |
| HY-106874 | Delequamine | Antagonist | / | Unkown |
| HY-106964A | (Rac)-S 16924 | Agonist | / | Unkown |
| HY-107370S | Atomoxetine-d7 | Inhibitor | / | Unkown |
| HY-107370S1 | Atomoxetine-d5 | / | Unkown | |
| HY-108021 | HT-61 | Inhibitor | / | Unkown |
| HY-108057 | Facinicline | / | Unkown | |
| HY-108252 | SB-649915 | Antagonist | / | Unkown |
| HY-108256S | Melitracen-d6 hydrochloride | Inhibitor | / | Unkown |
| HY-109065 | Minesapride | Agonist | / | Unkown |
| HY-109543 | Indisetron | Antagonist | / | Unkown |
| HY-111136 | BL-1020 mesylate | / | Unkown | |
| HY-111156 | NW-1172 free base | Inhibitor | / | Unkown |
| HY-111291 | ICI 169369 free base | Inhibitor | / | Unkown |
| HY-111985 | Revospirone | / | Unkown | |
| HY-116065 | CUMI-101 | Agonist | / | Unkown |
| HY-116554 | GYKI-46903 | Antagonist | / | Unkown |
| HY-116581 | 5-HT7R antagonist 4 | Antagonist | / | Unkown |
| HY-116603 | SB-236057 | / | Unkown | |
| HY-116606 | LY108742 | Antagonist | / | Unkown |
| HY-116680 | LY53857 | Antagonist | / | Unkown |
| HY-118209 | L 646462 | Antagonist | / | Unkown |
| HY-118317 | Zacopride | / | Unkown | |
| HY-118835S | Zimeldine-d6 | / | Unkown | |
| HY-119389 | RGH-1756 | Antagonist | / | Unkown |
| HY-121574 | RU 27849 | Agonist | / | Unkown |
| HY-122272A | Paroxetine acetate | / | Unkown | |
| HY-122272S | Paroxetine-d4 | / | Unkown | |
| HY-123498 | MCI-225 (dehydratase) | / | Unkown | |
| HY-123514 | SNAP8719 free base | Antagonist | / | Unkown |
| HY-123707 | KPU-300 | Inhibitor | / | Unkown |
| HY-123747 | SC-53116 | Agonist | / | Unkown |
| HY-123747A | SC-53116 hydrochloride | Agonist | / | Unkown |
| HY-12560C | (S)-PNU-282987 hydrochloride | / | Unkown | |
| HY-12855 | Lys01 | Inhibitor | / | Unkown |
| HY-128715 | Fluperlapine | Antagonist | / | Unkown |
| HY-129265 | Poloxin-2 | Inhibitor | / | Unkown |
| HY-129444 | MD 780236 free base | Inhibitor | / | Unkown |
| HY-132348S | Granisetron-d3 | Antagonist | / | Unkown |
| HY-133790 | Palonosetron N-oxide | Control | / | Unkown |
| HY-133828 | Cinanserin | / | Unkown | |
| HY-135194 | Risperidone E-oxime | 98.97% | Unkown | |
| HY-13575S1 | Blonanserin-d5 | Antagonist | / | Unkown |
| HY-136700 | SB-699551 free base | / | Unkown | |
| HY-136880 | Flufylline | Antagonist | / | Unkown |
| HY-137111 | p-MPPF dihydrochloride | / | Unkown | |
| HY-137111A | p-MPPF | / | Unkown | |
| HY-137161 | 6-Nitroquipazine | Inhibitor | / | Unkown |
| HY-137162 | Dotarizine | Inhibitor | / | Unkown |
| HY-138237 | 25I-NBMD hydrochloride | Agonist | / | Unkown |
| HY-138257A | (R)-Indeloxazine benzenesulfonate | Inhibitor | / | Unkown |
| HY-138818 | N,O-Didesmethylvenlafaxine | / | Unkown | |
| HY-139045 | 2,4-DMA hydrochloride | Agonist | / | Unkown |
| HY-139382 | 2-(Isopentylamino)naphthalene-1,4-dione | Inhibitor | / | Unkown |
| HY-14149S | Cisapride-d6 | / | Unkown | |
| HY-14909R | Bardoxolone (Standard) | / | Unkown | |
| HY-149670 | Ferroptosis-IN-3 | Inhibitor | / | Unkown |
| HY-151542 | MLKL-IN-4 | Inhibitor | / | Unkown |
| HY-15401A | WAY 163909 (hydrochloride) | Agonist | / | Unkown |
| HY-15414S1 | Vortioxetine-d6 | Inhibitor | / | Unkown |
| HY-15414S2 | Vortioxetine-d4 | / | Unkown | |
| HY-15543 | CP-809101 | Agonist | / | Unkown |
| HY-156562B | 5-PT TFA | / | Unkown | |
| HY-158702 | 5-HTQ chloride | Agonist | / | Unkown |
| HY-159689 | Cloroperone | Inhibitor | / | Unkown |
| HY-164011 | Alaproclate | Inhibitor | / | Unkown |
| HY-164467 | CCT070535 | Inhibitor | / | Unkown |
| HY-167646 | Ammuxetine | / | Unkown | |
| HY-167663 | Ebalzotan | / | Unkown | |
| HY-168747 | 4-Bromo-2,5-DMMA | Ligand | / | Unkown |
| HY-168809 | Norbaeocystin | Control | / | Unkown |
| HY-169140 | Zalospirone | Agonist | / | Unkown |
| HY-169239 | MAGL-IN-20 | Inhibitor | / | Unkown |
| HY-169440 | 6-Fluoro-N,N-diethyltryptamine | Ligand | / | Unkown |
| HY-169448 | Ethylpropyltryptamine | Agonist | / | Unkown |
| HY-169735 | Aurora A inhibitor 4 | Inhibitor | / | Unkown |
| HY-170367 | Antimicrobial agent-35 | Inhibitor | / | Unkown |
| HY-170474 | 2-Methyl-N,N-dimethyltryptamine | Ligand | / | Unkown |
| HY-171906 | 1-Arachidonoyl-2-hydroxy-sn-glycero-3-PA | Inhibitor | / | Unkown |
| HY-17410S2 | Iloperidone-13C,d3 | Antagonist | / | Unkown |
| HY-175213 | Mutant IDH1-IN-7 | Inhibitor | / | Unkown |
| HY-17637S2 | Lumateperone-d4 | / | Unkown | |
| HY-180329 | CG 858-Neg | / | Unkown | |
| HY-184052 | 5-HT4R agonist-3 | / | Unkown | |
| HY-184351 | CP 132484 | Agonist | / | Unkown |
| HY-186238 | VVZ-068 | Antagonist | / | Unkown |
| HY-19100 | ADX-10061 | Antagonist | / | Unkown |
| HY-19417A | Wf-516 | / | Unkown | |
| HY-19658 | Serazapine | Antagonist | / | Unkown |
| HY-19682 | Enciprazine | / | Unkown | |
| HY-19684 | Pancopride | Antagonist | / | Unkown |
| HY-19927A | DA-6886 monohydrochloride | Agonist | / | Unkown |
| HY-32329S | Setiptiline-d3 | / | Unkown | |
| HY-401563 | 5-HT2A antagonist 4 methanesulfonate | Antagonist | / | Unkown |
| HY-44132A | Dehydro Palonosetron hydrochloride | Antagonist | / | Unkown |
| HY-70050CS | Alosetron-d3 hydrochloride | Antagonist | 99.0% | Unkown |
| HY-A0039S | Eletriptan-d3 | Agonist | / | Unkown |
| HY-B0031S2 | Quetiapine-d8 fumarate | / | Unkown | |
| HY-B0071AS | Granisetron-d6 Hydrochloride | Antagonist | / | Unkown |
| HY-B0071S1 | Granisetron-d4 | / | Unkown | |
| HY-B0071S2 | Granisetron-d6 | Antagonist | / | Unkown |
| HY-B0072S | Tropisetron-d5 | / | Unkown | |
| HY-B0196AS | Venlafaxine-d10 hydrochloride | Inhibitor | / | Unkown |
| HY-B0196S2 | Venlafaxine-d4 | Inhibitor | / | Unkown |
| HY-B0196S3 | Venlafaxine-d10 | Inhibitor | / | Unkown |
| HY-B0197S | Naratriptan-d3 | Agonist | / | Unkown |
| HY-B0607S | Nitisinone-d3 | / | Unkown | |
| HY-B1213S | Trimipramine-d3 maleate | / | Unkown | |
| HY-B1287S | Citalopram-d3 hydrobromide | / | Unkown | |
| HY-B1396S3 | Nefazodone-d4 hydrochloride | Antagonist | / | Unkown |
| HY-B2169S2 | Melperone-d4 hydrochloride | 99.84% | Unkown | |
| HY-N10132 | Microgrewiapine A | Antagonist | / | Unkown |
| HY-N12430 | Marsdenoside A | / | Unkown | |
| HY-N12820 | 3-O-6-Deoxy-3-O-methyl-β-D-allopyranosyl-(1→4)-β-D-oleandropyranosyl-tenacigenin C | / | Unkown | |
| HY-N14415 | Cochleamycin A | Inhibitor | / | Unkown |
| HY-N14603 | Chandrananimycin A | Inhibitor | / | Unkown |
| HY-N14604 | Chandrananimycin B | Inhibitor | / | Unkown |
| HY-N2434A | (E)-[10]-Shogaol | Agonist | / | Unkown |
| HY-N3123 | Oxychelerythrine | / | Unkown | |
| HY-N9966 | Sanggenol O | / | Unkown | |
| HY-RS16313 | HT Human Pre-designed siRNA Set A | Pre-designed Set | / | Unkown |
| HY-U00028 | T 82 | / | Unkown | |
| HY-W007223 | D-5-Hydroxytryptophan | / | Unkown | |
| HY-W017424R | 2-Aminobenzothiazole (Standard) | / | Unkown | |
| HY-W022362 | 2-Aminotetralin | Agonist | / | Unkown |
| HY-W052508R | Norquetiapine (Standard) | Modulator | / | Unkown |
| HY-W1023070 | 4-fluoro MBZP | / | Unkown | |
| HY-W103498 | N4,N4'-Diphenyl-N4,N4'-bis(9-phenyl-3-carbazolyl)biphenyl-4,4'-diamine | / | Unkown | |
| HY-W355652 | Fluvoxamine acid | Inhibitor | / | Unkown |
| HY-W362839 | Binospirone | Agonist | / | Unkown |
| HY-W394935 | Dixylyl disulphide | / | Unkown | |
| HY-W615141 | Desmethyltrimipramine | 98.03% | Unkown | |
| HY-W670700 | 2,5-Dihydroxy-4-methoxyacetophenone | Inhibitor | 98.55% | Unkown |
| HY-W680886 | 6-APDB | / | Unkown | |
| HY-W700240 | Triazolomethylindole-3-acetic acid | Control | / | Unkown |
| HY-W703869 | 5-Hydroxy NMT oxalate | / | Unkown | |
| HY-W708033 | 25E-NBOMe hydrochloride | Agonist | 99.9% | Unkown |
| HY-W713312 | 2,6-DMA hydrochloride | Agonist | / | Unkown |
| HY-W728110 | 5-MeO-pyr-T | Agonist | / | Unkown |
| HY-W740014 | N-Desmethyl Zolmitriptan | Agonist | / | Unkown |
| HY-W754019 | Cinuperone | / | Unkown | |
| HY-W928623 | 2-Acetylthiophene thiosemicarbazone | Inhibitor | / | Unkown |
| HY-Z6430 | Des-4-fluorobenzyl mosapride | Agonist | / | Unkown |
| HY-U00322 | 5-HT3 antagonist 3 | Antagonist | / | Unkown |
| HY-101690 | QF0301B | Antagonist | / | Unkown |
| HY-U00126 | 5HT6-ligand-1 | / | Unkown | |
| HY-U00234 | Zatosetron maleate | Antagonist | / | Unkown |
| HY-U00365 | 5-HT2 antagonist 1 | Antagonist | / | Unkown |
| HY-U00367 | (4E)-SUN9221 | Antagonist | / | Unkown |
| HY-U00368 | 5-HT3 antagonist 1 | Antagonist | / | Unkown |
| HY-U00408 | 5-HT3 antagonist 2 | Antagonist | / | Unkown |
| HY-U00413 | 5-HT3-In-1 | Inhibitor | / | Unkown |
Bioactive MoleculesInhibitory Antibodies
(1)
| Cat. No. | Product Name |
Effect
|
Purity |
Rare Diseases
|
|---|---|---|---|---|
| HY-P991068 | hT84.66-M5A | Inhibitor | 99.59% | Unkown |